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8ABSTRACT
Maintaining cellular homeostasis is a complex task, which involves 
monitoring energy states and essential nutrients, regulating metabolic fluxes to 
accommodate energy and biomass needs, and preventing buildup of potentially 
toxic metabolic intermediates and byproducts. Measures aimed at maintaining a 
healthy cellular economy inherently depend on the composition of nutrients 
available to the organism through its diet. We sought to delineate links between 
dietary composition, metabolic gene regulation, and physiological responses in 
the model organism C. elegans.  
 As a soil-dwelling bacterivore, C. elegans encounters diverse bacterial 
diets. Compared to a diet of E. coli OP50, a diet of Comamonas aquatica 
accelerates C. elegans developmental rate, alters egg-laying dynamics and 
shortens lifespan. These physiological responses are accompanied by gene 
expression changes. Taking advantage of this natural, genetically tractable 
predator-prey system, we performed genetic screens i) in C. elegans to identify 
regulators of diet-responsive genes, and ii) in E. coli and Comamonas to 
determine dietary factors driving transcriptional responses in C. elegans. We 
identified a C. elegans transcriptional program that regulates metabolic genes in 
response to vitamin B12 content in the bacterial diet. Interestingly, several B12-
repressed metabolic genes of unknown function are highly activated when B12-
dependent propionyl-CoA breakdown is impaired, and inactivation of these genes 
9renders animals sensitive to propionate-induced toxicity. We provide genetic and 
metabolomic evidence in support of the hypothesis that these genes form a 
parallel, B12-independent, β-oxidation-like propionate breakdown shunt in C. 
elegans, similar to the pathway utilized by organisms like yeast and plants that 
do not use vitamin B12.  
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CHAPTER I: INTRODUCTION
Preface
This introduction chapter is adapted from a review written by myself and 
Marian Walhout published in the journal Trends in Endocrinology and Metabolism 
in 2014, titled, “Caenorhabditis elegans metabolic gene regulatory networks 
govern the cellular economy.” [1] 
Introduction
Diet greatly impacts metabolism in health and disease. In response to the 
presence or absence of specific nutrients, metabolic gene regulatory networks 
sense the metabolic state of the cell and regulate metabolic flux accordingly, for 
instance by the transcriptional control of metabolic enzymes. Many diseases are 
characterized by disruption of metabolic homeostasis, including inborn errors of 
metabolism (cumulative incidence estimated at 1 in 784 live births [2], as well as 
multifactorial diseases such as diabetes (2.8% worldwide incidence in 2000, 
estimated to double by 2030 [3]). For patients with genetic metabolic disorders, 
diet can be therapeutic or detrimental, depending on the composition and 
quantities of dietary nutrients and the nature of the metabolic impairment. Diet 
can also have a primary causal role in diseases such as obesity and type II 
diabetes [4], however the mechanisms by which diet can lead to metabolic 
syndrome and insulin resistance are not fully understood.  
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The bacterivorous nematode Caenorhabditis elegans has been used to 
great effect to elucidate mechanisms of metabolic network regulation. C. elegans 
has similar auxotrophic requirements compared with humans, including the same 
essential amino acids and vitamins. Additionally, C. elegans maintains 
orthologous metabolic pathways, as well as canonical metabolic regulatory 
pathways such as insulin signaling and TOR (target of rapamycin) signaling. C. 
elegans provides clear advantages compared to mammals for system-level 
studies of metabolism. The nematode is small (~1.5 mm), has a transparent 
body, a short lifespan (~2-3 weeks), and a well-annotated genome [5, 6]. In 
addition, a variety of genome-wide technologies and resources enable the 
genome-scale characterization of metabolic phenotypes, for instance in response 
to dietary changes. These include two genome-wide RNAi libraries [7, 8] and a 
growing number of deletion mutants generated and maintained by the 
Caenorhabditis Genetics Center (CGC). In addition, large-scale protein-protein 
and protein-DNA interaction mapping efforts have identified many molecular 
connections that can be integrated with phenotypic data [9-11]. These tools have 
in recent years helped researchers gain new insights into metabolic gene 
regulatory networks.  
 Several principles have begun to emerge with respect to C. elegans 
metabolic gene regulatory networks – a modular organization of transcription 
factors (TFs) and targets, an enrichment of nuclear hormone receptors (NHRs) 
among the transcriptional regulators, feedback between metabolic pathways and 
19
their regulators, and the capacity to sense various metabolite signals, which are 
dependent on diet and metabolic flux.  
Metabolic regulatory networks are enriched for nuclear hormone receptors
 
Transcriptional regulation provides a major mechanism of metabolic 
network control, and diet-induced metabolic gene expression changes have been 
observed in organisms ranging from bacteria to humans. In mammals, many 
metabolites have regulatory power. For instance, glucose triggers the insulin 
signaling cascade, which represses the transcription of gluconeogenesis genes 
[12], and amino acids such as leucine activate the TOR pathway, which controls 
gene product expression at the translational level [13]. These nutrient-sensing 
pathways are central to cell survival, growth and proliferation. Other metabolites 
interact directly with NHRs to modulate their function, such as vitamin A 
activating the retinoic acid receptor [14], vitamin D activating the vitamin D 
receptor [15], and free fatty acids and eicosanoids binding to peroxisome 
proliferator-activated receptor alpha (PPARα) [16]. Aberrant transcriptional 
control of metabolic pathways and subsequently altered metabolic flux, especially 
pertaining to fatty acids, are hallmarks of diabetes. Indeed, PPARα, a lipid-
sensing NHR that promotes lipid catabolism is a target of anti-diabetic drugs [17]. 
 Interestingly, the NHR family has greatly expanded in nematodes: 
whereas humans and mice have 48 and 49 NHRs, respectively, the C. elegans 
genome encodes 274 receptors [18]. While ligands have been identified for many 
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human NHRs, only one ligand has been identified for a C. elegans NHR 
(dafachronic acid, which binds and activates DAF-12 [19, 20]). Thus, all other C. 
elegans NHRs are currently orphan receptors, and the gene targets of the vast 
majority of NHRs remain undefined. Yeast-one-hybrid assays have identified the 
repertoire of TFs that can interact with a set of C. elegans metabolic gene 
promoters [21]. These TFs are enriched for NHRs [21], suggesting that, like their 
mammalian orthologs, C. elegans NHRs function in metabolic network control 
[17].  
Protein-DNA interaction networks indicate that the TFs that bind to C. 
elegans metabolic gene promoters tend to separate into densely interconnected 
modules with overlapping targets [21]. Modularity in biological networks has been 
proposed to facilitate rapid and robust responses to variable environmental cues 
[22-25]. In C. elegans, the NHR gene family expansion and functional 
organization into highly interconnected regulatory modules controlling metabolic 
genes may enable rapid and adaptive metabolic rewiring in response to different 
conditions, such as diet or environmental toxins. This network organization may 
provide the animal with a mechanism to ensure robust development and 
reproductive fitness on diets of highly metabolically diverse bacterial species 
encountered in its natural habitat (Figure 1.1). The current state of knowledge 
regarding C. elegans NHRs in metabolic regulatory roles is reviewed in Table 
1.1, and several examples are discussed throughout this review. 
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The role of diet in regulating the metabolic network
C. elegans can be found in temperate climates around the world and is 
likely to encounter a wide variety of bacterial species in its natural habitat [26]. 
Therefore, the worm must adjust to potentially large differences in macro- and 
micronutrients provided by different bacterial diets. C. elegans exhibit a range of 
differences in life history traits, including development rate, fecundity and 
lifespan, when fed different bacteria [27-30]. For instance, animals fed the soil 
bacterium Comamonas DA1877 develop faster, have fewer progeny, and a 
shorter lifespan than animals fed the standard E. coli OP50 diet. Gene 
expression profiling of C. elegans fed different bacterial diets revealed an 
enrichment of metabolic genes among differentially expressed genes [29, 31]. 
The promoter of one of the Comamonas-repressed transcripts corresponding to 
the metabolic gene acdh-1 was also repressed by the Comamonas diet using a 
transgenic GFP reporter [29], suggesting that the transcriptional regulation of 
metabolic genes in response to diet may be an important regulatory mechanism.  
 Relatively little is known about the mechanisms that govern the regulation 
of C. elegans metabolic genes in response to different bacterial diets, or how 
these changes lead to physiological changes in the animal. To dissect these 
mechanisms, it is pertinent to: (i) identify which C. elegans genes are involved in 
mediating a dietary response; (ii) determine which bacterial nutrients or 
metabolites drive the response; and (iii) characterize diet-specific phenotypes for 
22
metabolic and regulatory gene mutants to determine the biological significance of 
metabolic rewiring events.  
(i) Identifying C. elegans genes that control the metabolic response to diet
Genetic screens can be used to reveal C. elegans factors that control the 
expression of metabolic genes in response to diet. For instance, genome-scale 
RNAi and mutagenesis screens can be performed using transgenic animals that 
express green fluorescent protein (GFP) under control of a diet-responsive gene 
promoter. Unbiased, reporter-based screening approaches identified factors 
responsible for the transcriptional activation of xenobiotic metabolism genes in 
response to specific xenobiotic compounds [32], the repression of xenobiotic 
metabolism genes under normal conditions [33], and the induction of triglyceride 
lipases in response to starvation [34]. NHRs have also emerged as important 
mediators in the response of drug metabolism genes to toxic xenobiotic 
compounds. For instance, nhr-176 is required for inducing expression of the 
cytochrome P450 cyp-35d1 specifically in response to thiabendazole, an 
antifungal/antiparasitic drug. Interestingly, knockdown of nhr-176 by RNAi 
negatively affects fertility when animals are exposed to thiabendazole, but not 
under normal conditions [32]. In humans, NHRs including the pregnane X 
receptor (PXR) and constitutive androstane receptor (CAR) are known to play 
pivotal roles in the induction of detoxifying cytochrome P450’s by xenobiotic 
compounds [35]. 
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(ii) Identifying metabolite signals that drive responses to different bacterial diets
Bacterial nutrients that induce a response in C. elegans can be identified 
in different ways. For instance, metabolomics might reveal differences in nutrient 
levels between bacterial diets. However, the number of metabolites that can be 
measured is rather limited and usually there are multiple differences in nutrient 
levels, thus identifying the key nutrients driving physiological responses in C. 
elegans is difficult (see below for more discussion on Metabolomics). Another 
approach is to identify mutant bacterial strains that, when fed to C. elegans elicit 
a distinct response from the wild type diet. For instance, a strain of E. coli HT115 
with a spontaneous mutation in the aroD gene was serendipitously found to 
extend lifespan when fed to C. elegans. This mutation reduces bacterial folate 
synthesis, which extends lifespan in C. elegans [36]. Similarly, by feeding a nitric 
oxide synthase-deficient Bacillus subtilis strain and comparing the effects to a 
wild type Bacillus subtilis diet, it was discovered that bacterially supplemented 
nitric oxide can impact C. elegans longevity [37]. Possibilities for unbiased 
screening of bacterial mutants are emerging, as bacterial mutant libraries such 
as the E. coli Keio collection have recently been developed [38, 39]. 
(iii) Characterizing dietPspecific phenotypes
Diet-specific phenotypes have been characterized for metabolic gene mutants 
[31, 40, 41], and can indicate differential requirements for metabolic pathways on 
different diets. One metabolic gene with a diet-specific phenotype is alh-6, which 
is involved in the breakdown of proline. alh-6 mutants exhibit normal lifespan 
24
when fed E. coli HT115, but exhibit reduced lifespan when fed E. coli OP50 or E. 
coli HT115 supplemented with excess proline [40]. Knockdown of the enzyme 
directly upstream of alh-6, prodh, eliminated the negative effect of proline on alh-
6 mutant longevity [40]. This suggests that the proline breakdown intermediate 
and alh-6 substrate 1-pyrroline-5-carboxylate (P5C) builds up in the alh-6 mutant, 
and negative affects longevity in these animals [40]. 
 Diet-specific phenotypes have not only been observed for metabolic 
genes but also for the regulators of metabolic genes. A diet-specific phenotype 
can indicate a role for that particular regulator in diet-induced metabolic rewiring. 
For instance, nhr-114, which targets stress response and detoxification genes 
(including cytochrome P450’s, UDP-glucuronosyltransferases and glutathione S-
transferases) and lipid metabolism genes (lipl-2, acs-10) [42], was identified in an 
RNAi screen for factors that are necessary for germline development [42]. 
Surprisingly, the associated sterility phenotype was diet-dependent: nhr-114 
mutants fed E. coli OP50 were sterile, while mutants fed E. coli HT115 were not 
[42]. Fertility could be restored in nhr-114 mutants fed E. coli OP50 if the diet was 
supplemented with tryptophan [42]. The rescue by tryptophan is likely due to its 
conversion by E. coli to another as-yet-undetermined bacterial metabolite, as its 
effect required a living bacterial diet [42].  
 nhr-8 was also identified in an RNAi screen, this time for enhancers of daf-
36 null mutants, which have reduced dafachronic acid (DA) production and thus 
impaired daf-12 function [43]. nhr-8 mutants exhibit decreased DA production, 
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enhanced dauer formation and gonad migration defects, and these phenotypes 
are mitigated by dietary cholesterol supplementation [43]. Gene expression 
profiling of nhr-8 mutants revealed differences in lipid and DA metabolism gene 
expression [43], indicating a regulatory role in maintaining adequate levels of DA 
synthesis genes that utilize cholesterol as a precursor. Future studies will be 
required to determine whether nhr-8 and nhr-114 are ligand-gated, and whether 
their ligands are diet-derived. 
Metabolomics, transcriptomics, and proteomics– towards understanding
regulatory consequences to metabolic flux
The goal of regulating a metabolic gene is to regulate flux through the pathway in 
which the enzyme encoded by the gene functions. However, not all enzymes are 
regulated at the level of transcription; many can be regulated allosterically or by 
post-translational protein modifications. Thus, more directly measuring protein 
and metabolite levels may be required to uncover the outputs of transcriptional, 
allosteric and protein-modification changes. 
 Metabolomics is the simultaneous quantification of many different 
metabolites in a biological sample. Current technologies enable several hundred 
metabolites to be detected from biological samples, which is impressive 
considering the chemical diversity of these molecules. However, it only 
represents a small fraction of the thousands of metabolites present in the cell. In 
C. elegans, metabolomics using mass spectrometry and/or nuclear magnetic 
resonance (NMR) spectroscopy has uncovered metabolic signatures of insulin 
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receptor (daf-2) mutants [44-46], a peptide transport (pept-1) mutant [45], a 
histone deacetylase (sir-2.1) mutant [46, 47], mitochondrial mutants (isp-1, clk-1, 
mev-1, ucr-2.3, gas-1) [46, 48, 49], a TCA cycle (idh-1) mutant [46], fatty acid 
synthesis mutants (fat-5, fat-6, fat-7) [50], as well as wild type animals exposed 
to anoxic conditions [51]. For metabolic gene mutants, metabolomic profiling can 
shed light on the block caused by the lack of enzymatic function and its rippling 
effects throughout the metabolic network. For instance, aqueous and lipid 
fraction profiling of Δ9 desaturase mutants required for monounsaturated fatty 
acid (MUFA) synthesis revealed that a lack of these enzymes had far-reaching 
effects beyond just decreases in MUFAs, and the overall trend was a shift 
towards a catabolic state [50].  
 Integration of metabolomic data with transcriptomic and proteomic data 
can provide a more complete picture of how metabolic gene regulation affects 
metabolic flux. For instance, proteomic analysis of a peptide transport mutant, 
pept-1 (lg601), revealed 23 proteins with significantly altered abundance 
compared to wild type, and four of these were methionine/SAM cycle enzymes, 
which were all downregulated in the mutant. Metabolomics revealed increased 
homocysteine and decreased methionine levels accompanying the 
downregulation of methioine/SAM cycle enzyme expression, indicating reduced 
flux through this metabolic pathway in pept-1 mutants [45]. 
 One major challenge when interpreting metabolomics data is overcoming 
variability that naturally arises within a population of animals and across 
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experiments. In the study of various MUFA synthesis mutants (fat-5, fat-6, fat-7) 
the major principle component explaining the largest portion of sample variance 
in the metabolomics data was not genotype, but rather batch effects [50]. Two 
studies found that, surprisingly, the metabolomic differences between cohorts of 
wild type C. elegans fed two different E. coli strains (OP50 and HT115) were 
equal to, or greater than the metabolomic differences caused by perturbing daf-
2/insulin signaling [46, 52]. This suggests that C. elegans metabolic profiles are 
exquisitely sensitive to differences in diet and environment, as well as to 
genotypic differences. These two E. coli diets were previously shown to have 
different carbohydrate content, but similar protein and fat content [53], however 
differences in micronutrient content are yet to be determined. Importantly, since 
wild type animals fed E. coli OP50 and those fed E. coli HT115 are more-or-less 
equally fit [29], yet have different metabolomic and transcriptomic profiles [29], 
we can hypothesize that C. elegans may have a range of homeostatic metabolic 
states that are conducive to healthy development, reproduction and aging.  
Concluding remarks
C. elegans is a powerful model to study metabolic regulatory networks, 
and how they connect diet to gene expression and physiology. The nematode is 
extremely well suited to provide valuable insights into mammalian metabolic 
networks, as its core metabolic pathways share significant homology to their 
human counterparts. C. elegans and mammals also share a similar suite of 
nutrient auxotrophies and thus dietary requirements. Its amenability to genetic 
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manipulation and high content “omics” data generation makes C. elegans a 
valuable tool in the study of gene networks. Reverse genetics approaches, such 
as high-throughput RNAi screening with genome-wide or targeted mini-libraries, 
have been applied to the task of identifying members of metabolic gene 
regulatory networks. With the emergence of transgenic tools that report 
transcriptional responses to different diets or metabolites, used in conjunction 
with high-throughput screening, researchers will be able to map the gene 
networks responsible for sensing the metabolome and transmitting that 
information to the genome. Additionally, bacterial mutant collections like the E. 
coli Keio deletion library can be used to identify components within the diet that 
affect C. elegans physiology or metabolic gene expression, in an unbiased 
fashion.  
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Figures
 
Figure 1.1 – C. elegansmetabolic gene regulatory networks.  
Model illustrating principles of metabolic regulation in the worm. C. elegans likely 
encounters a wide variety of bacterial diets with different nutrient composition in 
the wild. These nutritional differences trigger transcriptional changes in metabolic 
genes, mediated by gene regulatory networks enriched for NHRs. Yeast one-
hybrid studies have revealed that metabolic gene regulatory networks are highly 
modular, which may ensure the rapid and coordinated response of metabolic 
pathways to environmental cues. Metabolic genes can also be regulated post-
transcriptionally by microRNAs. Feedback between NHRs and metabolic 
pathways via metabolite signals may be an important mechanism for regulating 
metabolic flux and maintaining cellular homeostasis on diverse diets. 
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NHR Ref. Metabolic Targets Physiological Role 
daf-12 [54, 55] 
TCA cycle enzymes  
(e.g. cts-1, aco-1)*;  
Fatty acyl-transferases (e.g. acl-1, 
acl-2 & acl-4)* 
short-chain dehydrogenases/ 
reductases (e.g. dhs-21 & dhs-26) 
 Required for proper developmental timing; 
mutants are heterochronic 
nhr-8 [43] Sterol, lipid and dafachronic acid metabolism genes 
On cholesterol-deficient diets, nhr-8 partial 
loss-of-function mutants display enhanced 
dauer formation, gonad migration defects, and 
larval arrest at high temperatures 
nhr-176 [32] cyp-35d1 Knockdown of nhr-176 causes reduced fertility when animals are exposed to thiabendazole 
nhr-49 [56, 57] fatty acid metabolism genes 
 Impairment of nhr-49 results in a high fat 
phenotype and reduced lifespan, as well as 
decreased oxygen consumption rates and 
abnormal mitochondrial morphology. 
nhr-80 [57-59] 
Fatty acid desaturases fat-5, fat-6 
and fat-7 
 Required for increased lifespan induced by 
loss of the germline; also required for proper 
mitochondrial morphology and oxygen 
consumption. Binds nhr-49 and has 
overlapping targets. 
nhr-66 [57] 
Sphingolipid and lipid remodeling 
genes; carbohydrate metabolic 
processes 
Mutants exhibit reduced basal oxygen 
consumption and beta-oxidation rates. Binds 
nhr-49 and has overlapping targets. 
nhr-62 [60] Fatty acid localization and transport genes 
Regulates dietary restriction (DR)-induced 
genes; overexpression leads to DR-like 
phenotypes such as small body size, reduced 
fat and increased longevity  
nhr-40 [61, 62] 
Lipid binding proteins, ATPases, 
glycolysis and TCA cycle genes Required for larval development  
nhr-114 [42] 
Stress response and 
detoxification genes and some 
lipid metabolism genes 
Mutant is sterile on the E. coli OP50 diet, but 
fertile on the E. coli HT115 diet. Sterility on E. 
coli OP50 is rescued by a tryptophan-derived 
E. coli metabolite 
nhr-64 [63]  Fatty acid metabolism genes 
 Knockdown partially suppressed the 
developmental delay caused by sbp-1 
mutation. Also partially suppressed 
developmental delay and reduced fertility of 
fat-6;fat-7 double mutant. 
*Representative targets of DAF-12 from enriched metabolic GO categories based on ChIP data 
Table 1.1 – Nuclear Hormone Receptors that regulate C. elegansmetabolism
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CHAPTER II: INTEGRATION OF METABOLIC AND GENE
REGULATORY NETWORKS MODULATES THE C. ELEGANS DIETARY
RESPONSE
 
Preface
This research chapter derives from work that Lesley MacNeil and I started 
in 2010, based on an observation by Efsun Arda that the Pacdh-1::GFP 
transgene was expressed differently on E. coli HT115 vs E. coli OP50. This 
prompted Lesley MacNeil to test the transgene on other diets, and found the 
dramatic effect elicited by Comamonas DA1877. Lesley and I worked closely to 
characterize the response of C. elegans to Comamonas, and this chapter is 
adapted from our 2013 publication in Cell titled “Integration of metabolic and 
gene regulatory networks modulates the C. elegans dietary response.” [64] In 
this work, Lesley and I share first authorship, and the other authors on the paper 
are Efsun Arda, Julie Zhu, and Marian Walhout.  
 Lesley is responsible for the content of Figures 2.1 and 2.2, and Table 2.1, 
which describe the results of the EMS screen and mutant mapping, sequencing, 
and characterization, which were done by Lesley. Lesley is also responsible for 
Figure 2.9c, d, and e, and Table 2.4, which describe the gene expression 
changes observed in Δpcca-1 and Δmetr-1 mutants. Julie Zhu analyzed the raw 
microarray data for these experiments, and helped map the genome sequencing 
data. Lesley and I worked jointly to generate the data in Figure 2.11a.  
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Abstract
Expression profiles are tailored according to dietary input. However, the networks 
that control dietary responses remain largely uncharacterized. Here, we combine 
forward and reverse genetic screens to delineate a network of 184 genes that 
affect the C. elegans dietary response to Comamonas DA1877 bacteria. We find 
that perturbation of a mitochondrial network comprised of enzymes involved in 
amino acid metabolism and the TCA cycle affects the dietary response. In 
humans, mutations in the corresponding genes cause inborn diseases of amino 
acid metabolism, most of which are treated by dietary intervention. We identify 
several transcription factors (TFs) that mediate the changes in gene expression 
upon metabolic network perturbations. Altogether, our findings unveil a 
transcriptional response system that is poised to sense dietary cues and 
metabolic imbalances, illustrating extensive communication between metabolic 
networks in the mitochondria and gene regulatory networks in the nucleus. 
Introduction
To maintain homeostasis, a cell must be able to sense its own energy state, 
assess nutrient availability, and modulate metabolic pathways in a coordinated 
fashion. Organisms utilize and integrate endocrine, allosteric and transcriptional 
mechanisms to respond to nutrients and activate or repress appropriate 
metabolic pathways accordingly. Different diets provide nutrients in different 
proportions and affect the transcription of metabolic genes in different ways. 
33
Dramatic changes in gene expression occur following dietary shifts in C. elegans, 
D. melanogaster and M. musculus [29] [65, 66]. 
Ensuring optimal metabolic tuning to complex dietary signals requires 
integration of nutrient sensors and their downstream targets to produce a 
coherent response. Studies in yeast have revealed co-expression of metabolic 
enzymes as a central mechanism of nutrient response. For example, the yeast 
TF Gcn4 activates enzymes involved in amino acid synthesis upon amino acid 
starvation [67]. This type of coordinated, need-based metabolic transcriptional 
response to nutrients is an important mechanism in yeast, but the extent to which 
it occurs in more complex multicellular organisms, remains largely unknown.  
Inborn errors of metabolism are relatively rare recessive disorders that are 
characterized by a buildup of metabolites that cannot be processed and/or a lack 
of metabolites required for basic cellular processes [68]. Patients with such 
diseases can display a variety of symptoms such as failure to thrive, 
developmental delay and seizures [69]. These diseases are often clinically 
managed by altering the patient’s diet to avoid buildup of toxic metabolites and to 
supplement limiting nutrients. For example, maple syrup urine disease, a 
disorder in which patients fail to catabolize the branched chain amino acids 
(BCAAs) leucine, isoleucine or valine, is managed by limiting the intake of 
protein-rich foods. 
The nematode C. elegans is a free-living bacterivore that is a genetically 
tractable model instrumental in understanding mechanisms relating to human 
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disease. For instance, genome-scale RNA interference (RNAi) resources have 
been used to identify essential genes [7, 70], genes affecting fat storage [71], 
and other processes. Further, the animal is transparent, which has enabled the 
use of the green fluorescent protein (GFP) to monitor spatiotemporal gene 
expression in living animals [72-75]. The core metabolic networks and major 
nutrient sensing pathways, including insulin and TOR, are highly conserved 
between C. elegans and humans. However, the transcription factor (TF) family of 
nuclear hormone receptors (NHRs) that regulate metabolic gene expression has 
greatly expanded, with a total of 271 members, compared to 48 in humans [76, 
77]. NHRs function as ligand-gated TFs and are postulated to provide the animal 
with a repertoire of responses to different environmental conditions [78, 79]. 
 C. elegans exhibits an altered gene expression profile when fed a 
bacterial diet of Comamonas DA1877 compared to the standard laboratory diet 
of E. coli OP50, and these changes are accompanied by altered life-history traits 
such as developmental rate, number of offspring and lifespan [29]. The metabolic 
gene acdh-1 exhibits the most dramatic change in expression between these 
diets. We developed a ‘dietary sensor’ strain comprising the acdh-1 promoter 
driving the expression of GFP: when fed the standard laboratory diet of E. coli 
OP50 GFP expression is high, but on a Comamonas DA1877 diet GFP 
expression is dramatically reduced. 
Here, we perform forward and reverse genetic screens to identify genes 
that can alter the transcriptional response to diet. We identify 184 genes, 
35
including 146 ‘activators’ and 38 ‘repressors’. Most of the 38 repressors encode 
enzymes that function within four mitochondrial metabolic pathways: BCAA 
breakdown, methionine metabolism, glycine cleavage system, and the TCA 
cycle. Human orthologs of most of the dietary response repressors confer inborn 
diseases of amino acid metabolism when mutated. In addition to acdh-1, the 
transcription of several other metabolic genes from these four pathways is 
modulated in response to both diet and metabolic network perturbations. These 
genes represent two modules that exhibit reciprocal behavior – one module, 
which includes acdh-1, is repressed by Comamonas DA1877 but activated by 
specific metabolic network perturbations, while the other is activated by 
Comamonas DA1877 but repressed by these metabolic network perturbations. 
We identify the TFs SBP-1, NHR-10 and NHR-68 as candidate mediators of the 
response to metabolic perturbations. Taken together, we uncover extensive 
communication between mitochondrial metabolic networks and nuclear gene 
regulatory networks, which may serve to optimize metabolic flux under different 
dietary and/or metabolic conditions. 
Results
A Forward Genetic Screen for Repressors of the Dietary Sensor Pacdh41::GFP
Animals harboring the Pacdh-1::GFP dietary sensor display much lower levels of 
GFP expression when fed Comamonas DA1877 than when fed the standard 
laboratory diet of E. coli OP50 [29]. ACDH-1 has been annotated as an acyl-CoA 
dehydrogenase involved in beta-oxidation of short chain fatty acids [80], and as a 
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short branched chain acyl-CoA dehydrogenase involved in BCAA breakdown 
[81]. Sequence comparison of the ACDH-1 protein with the human ACADSB 
enzyme (which functions in BCAA breakdown) and the human SCAD enzyme 
(which functions in beta-oxidation) indicates that ACDH-1 more closely 
resembles ACADSB (Figure 2.1).  
We performed a forward genetic screen to identify genes that, when 
mutated, cause activation of the acdh-1 promoter on a Comamonas DA1877 diet. 
We mutagenized the dietary sensor strain, screened ~10,000 genomes and 
isolated 45 fertile F2 mutants that produced GFP positive offspring (Figure 2.2a). 
These mutants varied in both level and pattern of GFP expression. For example, 
some mutants displayed relatively broad expression in the intestine, hypodermis 
and muscle, while others express GFP only in the intestine (Figure 2.2b, Table 
2.1). We mapped 20 mutations to four chromosomes. Five mutants were 
selected for whole genome sequencing, one from each linkage group and one 
additional mutant from linkage group IV. We identified five mutations in four 
genes: mmcm-1, pccb-1, F32B6.2 and F25B4.1, all of which encode 
mitochondrial metabolic enzymes: mmcm-1 encodes methylmalonyl-CoA 
mutase, pccb-1 encodes the beta subunit of propionyl-CoA carboxylase and 
F32B6.2 encodes an ortholog of alpha methylcrotonoyl-CoA carboxylase. These 
three proteins are all involved in BCAA breakdown. The fourth gene, F25B4.1, 
encodes the T-protein of the glycine cleavage system. We have named F32B6.2 
‘mccc-1’ and F25B4.1 ‘gcst-1’ to reflect these annotated biochemical functions. 
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By complementation tests and sequencing we identified additional alleles of three 
of the four genes (Figure 2.2c).  
To verify that the mutations truly affect the expression of acdh-1, we 
examined endogenous mRNA levels in four mutants. When grown on 
Comamonas DA1877, all mutants showed an increase in acdh-1 mRNA levels 
relative to wild type animals, which confirms the results obtained with the dietary 
sensor (Figure 2.2d, orange bars). We found similar changes in expression of 
two other diet-responsive genes, acdh-2 and ech-6 in these mutants (Figure 
2.2d, and data not shown). When fed E. coli OP50, the expression of these 
genes was similar in wild type and mutant animals (Figure 2.2d, purple bars), 
demonstrating that the mutations do not cause a general increase in their 
expression. In three of the four mutants the expression of acdh-1 was lower on 
Comamonas DA1877 than on E. coli OP50, indicating that, they are still 
somewhat able to respond to dietary cues (Figure 2.2d, compare orange and 
purple bars). The dietary response was completely impaired only in the mmcm-
1(ww5) mutant (Figure 2.2d).  
The acdh-1 promoter not only responds to different bacterial diets, but is 
also repressed upon starvation [29, 80]. We tested the response to starvation in 
our mutants. When starved for 24 hours, mccc-1(ww4) mutant animals retain 
GFP expression, which indicates that the starvation response is impaired in 
these mutants as well. In contrast, in mmcm-1, pccb-1 and gcst-1 mutants GFP 
expression was reduced, indicating that the response to starvation is retained 
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(Figure 2.2e). mmcm-1(ww5) mutants are completely impaired in the dietary 
response (Figure 2.2d), but retain a starvation response, confirming our 
observation that these two responses are distinct [29]. Altogether, these 
observations show that the dietary sensor can respond not only to diet but also to 
endogenous metabolic network perturbations. 
A GenomePScale RNAi Screen For Pacdh41::GFP Activators and Repressors
To identify additional genes that can affect the dietary sensor, we explored the 
use of RNAi by feeding, which is carried out in E. coli HT115 bacteria [82]. When 
fed E. coli HT115, the Pacdh-1::GFP animals express intermediate levels of 
GFP, enabling us to identify both dietary sensor repressors and activators. In 
addition, we took advantage of the fact that Comamonas DA1877 can be diluted 
and still repress the dietary sensor [29]. Adding a small amount of Comamonas 
DA1877 to the E. coli HT115 RNAi feeding lawn repressed the dietary sensor, 
while maintaining RNAi knockdown efficiency (Figure 2.3a). This enabled us to 
perform a genome-scale RNAi screen in the presence of Comamonas DA1877 
(Figure 2.3b). 
We screened the ORFeome RNAi library, which covers more than half of 
all predicted protein-coding genes [83]. After screening the library once in each 
dietary condition, we obtained 836 hits (8%, Figure 2.3b). These hits were re-
arrayed and retested four times to remove false positives. The 554 genes that re-
scored in at least two of four retests were considered further. This list of hits 
contained many genes involved in general protein expression that may not 
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specifically affect the dietary sensor. To identify such potential false positives, we 
screened the 554 hits against another transgene, Pmir-63::GFP that also 
expresses GFP in the intestine, but is not sensitive to Comamonas DA1877 
(Figures 2.3a, 2.3b). We retained 179 high-confidence hits (~2% of the genes 
tested). Of these, 146 caused a decrease in GFP expression (activators), while 
33 caused an increase (repressors) (Table 2.2). 
We retrieved nhr-10 and mdt-15, known activators of acdh-1 [78], as well 
as two of the genes (mccc-1 and gcst-1) found in the forward genetic screen. The 
other two genes (mmcm-1 and pccb-1) were not retrieved, although they were 
present in the RNAi library. This could be due to the inherent variability and the 
relatively high false negative rate of RNAi experiments [7]. Indeed, when we 
retested these clones in a small-scale, directed RNAi experiment we found that 
their knockdown does increase GFP expression (data not shown). 
RNAi Screen Validation
To verify that the genes found by RNAi affect endogenous acdh-1 expression, we 
used quantitative RT-PCR (qRT-PCR) in wild type (N2) animals subjected to 
RNAi of 11 representative genes found in the screen. As shown in Figure 2.3c, 
the qRT-PCR recapitulated what was observed in the Pacdh-1::GFP dietary 
sensor strain for all 11 knockdowns.  
 We obtained C. elegans mutant strains for several genes found in the 
RNAi screen, including the TFs nhr-68 and hlh-11, and the enzymes ZK669.4, 
sams-5, sams-1 and metr-1 (Figure 2.4). We introduced each mutation into the 
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Pacdh-1::GFP dietary sensor strain and examined GFP levels on E. coli OP50 
and Comamonas DA1877 (Figure 2.3d). These mutants exhibited GFP 
expression levels that recapitulate the effects observed by RNAi: mutations in the 
enzymes and hlh-11 all activated GFP expression, whereas a deletion in nhr-68 
decreased GFP expression. Further, we confirmed the increased expression of 
endogenous acdh-1 in animals fed E. coli OP50 and Comamonas DA1877 by 
qRT-PCR in Δhlh-11 and Δsams-5 mutant animals (Figure 2.3e).  
 To probe potential functional relationships among the genes discovered in 
the genetic screens, we assessed their connectedness in WormNet, a 
probabilistic functional gene network constructed through integration of different 
data types ([84]. The combined 181 genes found by both the forward and reverse 
genetic screens are significantly connected in WormNet and form a closely linked 
functional network (P = 1.97e-78)(Figure 2.5). Thus, these 181 genes are more 
functionally interrelated than would be expected for a random set of genes, 
supporting the overall quality of the RNAi screen. 
Dietary Sensor Activators
The majority (74%) of the 146 activators are expressed in the intestine (Figure 
2.5), suggesting that they may act cell-autonomously. Gene Ontology (GO) 
analysis revealed an enrichment for several terms, including ‘growth’, ‘sex 
differentiation’ and ‘ribosome biogenesis’  (Figure 2.5). Several of these genes 
are predicted to function in a number of biological processes, including general 
gene expression, splicing and translation, metabolism and the regulation of 
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transcription (Figure 2.5). Since acdh-1 is also repressed in response to 
starvation, the dietary sensor strain cannot discriminate between genes involved 
in, or inducing, a starvation response and those involved in the dietary response. 
To identify which activators may mediate a starvation response and which may 
be more specific to the dietary response, we used two additional transgenic 
strains in which GFP expression is repressed by starvation, but not affected by 
bacterial diet (Pgst-4::GFP and PC53A3.2::GFP, Figure 2.6). We found 37 
activators that affect at least one of these transgenes, 12 of which affected both, 
indicating that they may induce or mediate a starvation rather than dietary 
response (Table 2.3). The remaining 109 activators were specific to Pacdh-
1::GFP. 
Pacdh41::GFP Repressors Function in Four Metabolic Pathways
The combined 35 dietary sensor repressors obtained in both screens are 
enriched for GO terms relating to metabolism, including ‘mitochondrion’, ‘TCA 
cycle’ and ‘acetyl-CoA catabolic process’ (Figure 2.5). Overall, 83% of these are 
annotated metabolic genes, compared to 15% of the activators, and the vast 
majority is expressed in the intestine (Figure 2.5). Interestingly, most (24) of the 
repressors encode enzymes specifically involved in four metabolic pathways: 
BCAA breakdown (n=8), methionine metabolism (n=5), the glycine cleavage 
system (n=2) and the TCA cycle (n=9)(Figure 2.7).  
 We wondered whether other genes in these pathways that were not 
retrieved in the genetic screens would affect the dietary sensor as well. We 
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obtained deletion mutants for two genes involved in BCAA breakdown (mce-1 
and pcca-1) and one from the methionine metabolism pathway (cbl-1) (Figure 
2.7). These deletions were introduced into the Pacdh-1::GFP dietary sensor 
strain. Deletions in mce-1 and pcca-1 both caused increased GFP expression on 
all three diets and a deletion in cbl-1 caused increased GFP on Comamonas 
DA1877 but not on E. coli OP50 (Figure 2.8). Altogether, these findings indicate 
that disrupting these four metabolic pathways affects the dietary response to 
Comamonas DA1877. The observation that loss of several individual genes 
within a common pathway can induce similar changes in the expression of acdh-
1 suggests that these perturbations may converge onto a common regulatory 
signal. 
 Interestingly, acdh-1 itself was found as a repressor in the RNAi screen 
(Table 2.2). We obtained an acdh-1 deletion mutant and introduced it into the 
Pacdh-1::GFP dietary sensor strain. We observed higher GFP levels in the 
Δacdh-1 mutant relative to the wild type dietary sensor strain when the animals 
were fed E. Coli OP50 or HT115 diets, but less of an increase on a Comamonas 
DA1877 diet. On the latter diet acdh-1 expression is normally low (Figure 2.9a). 
Thus, feedback on the acdh-1 promoter occurs mainly on diets where 
endogenous acdh-1 levels are normally high, suggesting acdh-1 expression is 
regulated according to need.  
 Cellular metabolic needs are unlikely to be met by modulating the 
expression of a single enzyme; rather enzymes within a metabolic pathway or 
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network may need to be coordinately regulated [85]. In addition to acdh-1, 
several other genes predicted to function within BCAA breakdown and 
methionine metabolism pathways are also transcriptionally regulated in response 
to diet (Figure 2.7) [29]. This suggests that these genes comprise (a) 
coordinately regulated module(s). We wondered whether these genes were also 
transcriptionally sensitive to metabolic network perturbation. We examined the 
expression of seven Comamonas DA1877-responsive genes (four from BCAA 
breakdown, two from methionine metabolism, and one NHR) by qRT-PCR in 
several mutant strains that exhibit altered acdh-1 expression (Δmetr-1, Δsams-1, 
Δmce-1, Δacdh-1, Δhlh-11 and Δnhr-68). We found that several BCAA 
breakdown genes, as well as nhr-68, are co-induced with acdh-1 in response to 
metabolic network perturbation (Figure 2.9b). This further supports the modular 
regulation of these functionally related genes, and indicates that this may 
perhaps be mediated by nhr-68 (see below). The expression of acdh-2, a close 
homolog of acdh-1, is also increased in an acdh-1 deletion mutant, which may 
indicate a compensation mechanism of acdh-2 for the loss of acdh-1 function. 
Interestingly, the Comamonas DA1877-induced gene cbs-1 [29] exhibited 
opposite behavior compared to the Comamonas DA1877-repressed genes as it 
is repressed in the metabolic gene mutants. 
 To characterize the transcriptomic response to metabolic gene 
perturbations in more detail, we performed a microarray expression profiling 
experiment with two metabolic gene mutants on a Comamonas DA1877 diet. 
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One of these genes, pcca-1, functions in BCAA breakdown while the other, metr-
1, is involved in methionine metabolism. The two mutations elicit highly similar 
changes in gene expression (Figure 2.9c), further suggesting that these two 
different metabolic mutations may cause similar metabolomic changes that may 
impinge on a common regulatory signal. Strikingly, most of the core genes that 
change in response to a Comamonas DA1877 diet also exhibited expression 
changes in one or both metabolic mutants [29] (Figure 2.9d). In fact, there are 
two modules of co-expressed genes that exhibit reciprocal behavior – one that is 
repressed by a Comamonas DA1877 diet but activated in the metabolic gene 
mutants, and one that is activated by a Comamonas DA1877 diet but repressed 
in the metabolic gene mutants (Figure 2.9e, Table 2.4). 
Human Orthologs of Pacdh41::GFP Repressors are Involved in Inborn Metabolic
Disease
Many metabolic reactions are evolutionarily conserved, and most of the C. 
elegans enzymes found in our genetic screens have human orthologs (Table 
2.2). Most of these are associated with inborn disorders of amino acid 
metabolism (Figure 2.10). For instance, we identified multiple orthologs of genes 
that, when mutated in humans, cause maple syrup urine disease, methylmalonic 
acidemia, homocystinuria or propionic acidemia. These diseases are 
characterized by toxic buildups of amino acids and intermediate metabolites, and 
are treated by limiting amino acid (protein) intake and supplementing vitamins 
and other cofactors (Figure 2.10). We also found orthologs of TCA cycle genes 
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that cause diseases such as lactic acidosis and pyruvate dehydrogenase 
deficiency. These may also result in the accumulation of intermediate 
metabolites, or in the inability to generate sufficient amounts of energy (ATP).  
Mutations in two C. elegans metabolic genes (Δmetr-1 and Δpcca-1) 
cause highly similar changes in gene expression (Figure 2.9c). metr-1 is the 
ortholog of human Methionine synthase (MTR), which when mutated, causes 
methylcobalamin (vitamin B12) deficiency. pcca-1 is the ortholog of human 
PCCA in humans, which when mutated causes propionic acidemia. Our 
observations suggest that mutations in these genes may result in similar 
metabolic effects. The human disorders caused by mutations in these genes are 
treated in part by supplementation with vitamin B12, and both disorders can be 
revealed by elevated propionylcarnitine levels in newborn screening [86]. This 
suggests that, as in C. elegans, these two human diseases have at least partially 
overlapping molecular phenotypes.  
Limited Involvement of TOR and Insulin Signaling Pathways in Response to Metabolic
Network Perturbations
To determine whether known nutrient sensing pathways such as TOR or 
the Insulin signaling pathway are involved in upregulating acdh-1 in response to 
metabolic network perturbations, we performed RNAi on a panel of genes from 
these pathways in metabolic mutants harboring the Pacdh-1::GFP transgene. 
Knockdown of daf-2 or daf-16 had no effect on GFP expression in any of the 
mutants. We also crossed the Δmetr-1 and Δacdh-1 metabolic mutations into a 
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transgenic strain expressing a DAF-16::GFP fusion protein to determine whether 
these metabolic mutants affected DAF-16 nuclear localization, and found that 
neither had any effect (data not shown). Thus, insulin signaling does not mediate 
the response to metabolic network perturbations. 
 The TOR pathway is an attractive candidate for mediating the effects of 
metabolic perturbations because it affects acdh-1 in wild type animals and is 
regulated by amino acid levels, specifically leucine [87]. We tested whether the 
TOR pathway is involved in mediating the response to endogenous metabolic 
network perturbations and found limited involvement (Figures 2.11a, 2.11b). 
Knockdown of rheb-1 or ruvb-1 reduced GFP levels in most metabolic gene 
mutants. However, in almost every case GFP was still higher in these mutant 
strains than in the wild type strain (Figure 2.11a, 2.11b). Therefore it is likely that 
TOR signaling may be partially involved in, but not solely responsible for, 
mediating the induction of acdh-1 in metabolic mutants 
Multiple TFs Affect the Response to Metabolic Network Perturbations
In wild type animals, both nhr-10 and nhr-23 activate the dietary sensor 
[29, 78, 88]. In the RNAi screen, we identified additional TFs that affect acdh-1 
expression, most of which are NHRs (Table 2.2). We knocked down nhr-10, nhr-
23, nhr-68, nhr-173 and nhr-74, as well as sbp-1 by RNAi in multiple metabolic 
gene mutants, and examined changes in GFP expression. We observed complex 
gene regulatory effects of different TFs (Figures 2.11a, 2.11b). First, sbp-1 RNAi 
resulted in a dramatic decrease in GFP expression in all animals tested, 
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indicating that SBP-1 might function at the top of the metabolic gene regulatory 
hierarchy. However, sbp-1 RNAi also reduced GFP expression in the two 
starvation-responsive transgenic strains (Table 2.3). Previously, SBP-1 has been 
shown to regulate genes involved methionine metabolism [89]. Altogether, these 
observations suggest that SBP-1 may be a general regulator of metabolic gene 
expression in the C. elegans intestine. Second, nhr-23 RNAi has only mild effects 
on GFP expression in most mutants, whereas it has stronger effects in the wild 
type sensor strain, suggesting that it primarily controls acdh-1 expression in 
response to diet. However, it is important to note that nhr-23 RNAi was 
performed under dilute conditions to avoid larval arrest. Third, nhr-10 and nhr-68 
knockdown dramatically reduces GFP expression in almost all mutants. For 
example, GFP levels in Δmce-1 and Δpcca-1 deletion animals are equivalent to 
those in wild type animals subjected to nhr-10 or nhr-68 knock down (Figure 
2.11b). Therefore nhr-10 and nhr-68 may mediate the increase in acdh-1 
expression in response to specific metabolic network perturbations. 
 Knockdown of nhr-10 in an nhr-68 deletion mutant or vice versa had little 
additional effect on GFP expression, indicating that these two NHRs may 
function together (Figure 2.11a). Knockdown of the other NHRs tested, nhr-173 
and nhr-74, had mild effects on GFP expression in wild type animals, and had 
similarly mild effects in the context of metabolic network perturbations. However, 
knockdown of nhr-173 further reduces GFP expression in an Δnhr-10 deletion 
mutant, indicating that these NHRs may function in parallel. 
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Conclusions
We have unraveled a complex network of genes that affect dietary gene 
expression in C. elegans. This network is likely not yet complete for several 
reasons. First, forward genetics identified mutations in four metabolic genes, and 
although we have multiple alleles for three of these genes, the screen is not yet 
saturated. Second, the reverse genetic RNAi screen has not revealed all genes 
involved, since the ORFeome RNAi library contains only half of all C. elegans 
protein-coding genes [83], and because RNAi screens are prone to a high false 
negative rate [7]. This is supported by the initial retrieval of only two of the four 
genes found by forward genetics, and the identification of additional genes 
through targeted analysis of mutants in the metabolic pathways involved. 
 We primarily focused on dietary sensor repressors, most of which encode 
mitochondrial enzymes. We found that these repressors function in an intricate 
feedback and compensation system that results in regulation of metabolic gene 
expression. This is perhaps best exemplified by the feedback in which deletion of 
acdh-1 results in an increase in its own promoter activity under dietary conditions 
when acdh-1 levels are normally high. We know that this feedback extends from 
acdh-1 to other genes involved in BCAA breakdown because additional genes in 
this pathway either change in expression in response to a Comamonas DA1877 
diet, confer an increase in acdh-1 promoter activity when perturbed, or both. 
Thus, as has been observed in simpler unicellular organisms such as bacteria 
and yeast [85], metabolic changes induced genetically or by diet, likely result in 
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disruption of metabolic flux that, in turn, elicit a compensatory transcriptional 
response of relevant metabolic genes. Altogether, our study reveals extensive 
communication between mitochondrial metabolic networks and nuclear gene 
regulatory networks that function to dial metabolic gene expression according to 
cellular or organismal need (Figure 2.12). 
The mechanisms by which information is relayed from the mitochondria to 
the nucleus remain poorly understood. There are several shared metabolites 
among the four metabolic pathways found in the screens, including acetyl-CoA, 
succinyl-CoA, pyruvate, lipoamide, and the cofactor cobalamin (vitamin B12) 
(Figure 2.7). These shared metabolites represent points of convergence for 
metabolic flux through each of the individual pathways. Perturbing flux through 
methionine metabolism by mutating metr-1, for instance, may affect flux through 
BCAA breakdown due to buildup or depletion of shared metabolites. This could 
explain the observation that several genes from these two pathways are co-
regulated in response to diet and metabolic perturbation in either pathway. These 
metabolites may mediate the communication from the mitochondria to the 
nucleus. It is well known that these metabolites have broad ranging effects on the 
cell. For instance, epigenetic effects can be mediated by histone acetylation, 
methylation and phosphorylation, which require acetyl-CoA, SAM and ATP, 
respectively. It is possible that overall or specific protein modification levels are 
affected by metabolic network perturbations, and result in changes in gene 
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expression. Further, these metabolites may directly or indirectly target TFs such 
as NHRs (see below). 
 Interestingly, there was a high degree of overlap in both upregulated and 
downregulated genes in the gene expression profiles of two metabolic gene 
mutants, Δmetr-1 and Δpcca-1. This suggests that the functional defects caused 
by perturbing either the BCAA breakdown pathway or methionine metabolism 
may elicit similar metabolomic shifts in the animal, which may impinge upon a 
common regulatory signal. Both metabolic gene mutations reverse many of the 
gene expression changes conferred by a Comamonas DA1877 diet in wild type 
animals. Two modules of co-expressed genes exhibit reciprocal ‘see-saw’ 
behavior: one module is repressed by a Comamonas DA1877 diet but activated 
in the metabolic mutants, while another is activated by a Comamonas DA1877 
diet but repressed in the metabolic gene mutants. This implies that both 
metabolic network perturbations and a Comamonas DA1877 diet converge onto 
the same regulatory network to elicit converse effects on the two modules, 
perhaps via two opposing regulatory signals (Figure 2.12). 
 NHR-10 directly binds the acdh-1 promoter [78] and mediates the 
induction of acdh-1 in response to metabolic network perturbations in several 
mutants, particularly those that function within BCAA breakdown. In addition, 
NHR-68 and several other NHRs either function together or in parallel with NHR-
10. Epistasis experiments with additional NHRs, as well as other TFs, will further 
illuminate their function in metabolic gene regulation. NHRs are ligand-regulated 
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TFs that may be able to directly sense metabolite accumulation and regulate 
genes accordingly. For instance, NHR ligands may be produced as a result of 
specific metabolic network perturbations. Alternatively, NHRs may be inactivated 
by a metabolite, and depletion of that metabolite upon network perturbation might 
result in NHR activation. Perturbation of different metabolic pathways may result 
in the accumulation or depletion of metabolites that may be sensed by different 
NHRs with overlapping downstream targets. Previously, we found functional 
modularity of NHRs in a C. elegans gene regulatory network [78]. Here, we find a 
modular organization at the level of metabolic gene expression. Together, these 
findings support a model in which gene regulatory network modules facilitate 
rapid responses to physiological and environmental cues.  
 Most dietary sensor repressors encode enzymes involved in inborn 
disorders of amino acid metabolism in humans. These diseases are usually 
treated by dietary interventions that are designed to avoid build-up of toxic 
metabolites, to supplement patients with metabolites that are depleted, and/or 
with cofactors that may improve residual enzyme activity (Figure 2.10)[69]. In C. 
elegans mutations in genes from different pathways within the metabolic network 
(BCAA and methionine metabolism) can cause highly similar changes in gene 
expression. Thus, it may be that a dietary regimen used to mitigate one type of 
metabolic disease may also be beneficial for another. C. elegans presents an 
attractive model with which transcriptomic changes in response to different diets 
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and metabolic network perturbations can be compared, and potentially can be 
used in screens for drugs or other small molecules that affect these changes. 
Our study establishes C. elegans as a powerful model to dissect the 
mechanisms of dietary responses, inborn metabolic diseases and the 
connections between them. It is likely that other parts of the metabolic network 
respond to different cues. We provide a framework to identify candidate sensors 
to these cues, and to combine these sensors with genetic screens and epistasis 
to dissect the mechanisms involved.  
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Figure 2.1 – Cartoon of Homology with ACDHP1 protein  
Cartoon depicting the ACDH-1 protein with percent sequence identity with human 
and C. elegans enzymes in the acyl-CoA dehydrogenase N-terminal (N), Middle 
(M) and C-terminal (C) domains indicated. 
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Table 2.1 – Effects of various metabolic mutations on Pacdh41::GFP expression.  
Levels of GFP expression within each compartment are shown (Green). In 
addition, the reported expression pattern according to Wormbase (WS234) of the 
mutated genes is shown (Purple).  
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sensor animals fed E. coli OP50 are indicated in the top-right corner of the 
respective panel. (E) qRT-PCR of endogenous acdh-1 mRNA in Δsams-5 and 
Δhlh-11 mutant compared to wild type animals fed E. coli OP50, E. coli HT115, or 
Comamonas DA1877. Changes in acdh-1 expression were plotted as log2 fold 
change compared to acdh-1 levels in wild type animals fed E. coli OP50, which 
was set to equal 0. Error bars indicated the standard error in three technical 
repeats. 
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Figure 2.4 – Cartoon of Deletion Mutants  
Cartoons depicting gene structures of deletion mutants used in these studies, 
with the exception of the Δmce-1 mutant for which the deletion has not been 
precisely mapped. Arrows indicate direction of transcription. Proteins are 
diagrammed to the right of the gene structures with N and C termini relative to 
depicted gene directionality. Color blocks on genes correspond to colored protein 
59
domains, which were determined using PFAM. Red lines on protein cartoons 
indicate the region affected by the deletion. Bold double lines separate two 
sections with different scales, indicated by the 1kb scale lines at the tops of each 
section. 
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Figure 2.5 – Functional Annotation of Pacdh41::GFP Regulators  
(A) Left – network indicating predicted functional connections between dietary 
sensor regulators in WormNet. Blue indicates dietary sensor activators and 
yellow indicates dietary sensor repressors. Right – receiver operator curve 
illustrating significance of connections shown on left. The dashed line on the 
diagonal indicates random associations. (B) Significantly enriched GO terms for 
dietary sensor activators. (C) Tissue expression and functional category 
distribution of dietary sensor activators, with and without ‘unknown’ (in grey). (D) 
Significantly enriched GO terms for dietary sensor repressors. (E) Tissue 
expression and functional category distribution for dietary sensor repressors, with 
and without ‘unknown’ (in grey).  
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Figure 2.6 – Two Transgenic Reporters That Respond to Starvation  
Two additional transgenic reporters, Pgst-4::GFP and PC53A3.2::GFP exhibit 
decreased GFP expression in response to starvation. The high confidence 
Pacdh-1::GFP activators identified in the RNAi screen were also screened 
against these two reporters to identify genes that are generally required to 
activate starvation-repressed genes under fed conditions, or that when knocked 
down trigger a starvation-like response in the animal. The results are listed in 
Table S3. 
 
 
71
 
 
Table 2.3 – Pacdh41::GFP activators that also activate other starvation reporters 
Pacdh-1::GFP activators from RNAi screen that caused decreased GFP 
expression when knocked down by RNAi in either the Pgst-4::GFP strain, the 
PC53A3.2::GFP strain, or both.  
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Figure 2.7 – Pacdh41::GFP Repressors are Enriched in Four Metabolic Pathways  
Cartoon of a metabolic map showing C. elegans BCAA breakdown, methionine 
metabolism, glycine cleavage system and TCA cycle. Rectangles indicate genes; 
circles are metabolites.  
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Figure 2.8 – Additional Mutants from Propionate and Methionine Metabolic
Pathways.  
Differential interference contrast (DIC) and fluorescent images of wild type 
animals compared to Δmce-1, Δpcca-1 and Δcbl-1 mutant animals harboring the 
dietary sensor, grown on either E. Coli OP50, E. Coli HT115 or Comamonas 
DA1877. 
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Figure 2.9 – Metabolic Feedback and Transcriptional Compensation  
(A) Increased acdh-1 promoter activity in Δacdh-1 mutants identifies feedback 
control. (B) qRT-PCR of seven genes (rows) in different strains (columns). (C) 
Overlap in gene expression changes between two metabolic gene mutants. (D) 
Overlap between genes that change in expression in the two metabolic gene 
mutants and those that change in response to a Comamonas DA1877 diet. (E) 
Opposite changes in gene expression in response to a Comamonas DA1877 diet 
versus metabolic network perturbations. See also Figure 2.4 and Table S4. 
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Table 2.4 – Gene expression changes in Δmetr41 and Δpcca41mutants
Core Comamonas response genes [29] that exhibit expression changes in the 
Δmetr-1 and Δpcca-1 mutants.  
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Figure 2.10 – Mutations in Orthologs of acdh41 Repressors Confer Human Inborn
Metabolic Disorders Relating to Amino Acid Metabolism.  
Network connecting dietary sensor repressors, C. elegans phenotypes, human 
orthologs, human inborn metabolic diseases and dietary treatments. Orange 
nodes – C. elegans phenotypes; colored squares – C. elegans genes found in 
the screen; diamonds – human orthologs/homologs; gray circles – human 
diseases; hexagons – nutrients. Red edges indicate dietary avoidance; green 
edges indicate dietary supplementation. Red – genes from BCAA breakdown & 
propionate metabolism; Blue – genes from methionine metabolism; Yellow – 
genes from the TCA cycle; Green – genes from glycine cleavage system; Gray – 
genes involved in harvesting electrons from reduced FADH2.  
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Figure 2.12 – Model Reflecting Feedback Between Mitochondrial Metabolic Networks
and Nuclear Gene Regulatory Networks
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Table 2.5 – RTPqPCR primers and Nanostring probe sequences.
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Experimental Procedures
Strains
C. elegans strains were grown as described [90]. N2 (Bristol) was used as the 
wild type strain. The following mutant strains were provided by the C. elegans 
Gene Knockout Consortium (CGC): nhr-68(gk708), sams-1(ok2946), cbl-
1(ok2954), mce-1(ok243), pcca-1(ok2282), metr-1(ok521), ZK669.4(ok3001), 
sams-5(gk147) and hlh-11(ok2944). The nhr-10(tm4695) mutant strain was 
provided by the National Bioresource Project, Japan. The Pacdh-1::GFP strain 
(VL749) is described in [29].  VL405 [Pmir-63::GFP + unc-119(+)] is described in 
[74]. BC12350 dpy-5(e907); sIs12119 [rCesC53A3.2::GFP + pCeh361] is 
described [91]. CL2166 dvIs19[pAF15(Pgst-4::GFP::NLS)] [92]. 
 
EMS Screen
VL749 animals were treated with 0.5% EthylMethylSulfoxide (EMS) for four 
hours. Mutagenized animals were transferred to Nematode Growth media (NGM) 
plates seeded with Comamonas DA1877 and allowed to lay eggs. Eggs were 
collected and 100 10 cm Comamonas DA1877-NGM plates were seeded with 50 
F1 animals each. F2 animals were screened for visible GFP. A single GFP-
positive F2 animal was picked from each F1 plate and transferred to individual 
plates. Of the 100 mutants, 45 were fertile and produced GFP-positive offspring 
when fed Comamonas DA1877.   
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Mutant Mapping
Chromosomal assignment was done by crossing mutants carrying the Pacdh-
1::GFP reporter into the CB4856 (Hawaiian) strain followed by SNP mapping of 
GFP positive pools of F2 animals as described [93]. Mutants that produced GFP 
positive F1 males were assigned to linkage group (LG) X. Primers used for 
chromosomal assignment are as described [94]. Following chromosomal 
assignment, fine mapping was undertaken for five mutants using chromosomal 
primers as described [93, 94]. We created him-5(e1467) lines carrying the 
Pacdh-1::GFP transgene and the mutation of interest to perform 
complementation tests. These him-5 lines were used to generate males that 
were crossed into mutant hermaphrodites carrying Pacdh-1::GFP, and assessed 
GFP expression in F1 animals grown on Comamonas DA1877. 
Whole Genome Sequencing
Before sequencing, mutants were outcrossed three times to N2 wild type 
animals. Total genomic DNA was prepared for mutants ww2, ww4, ww10, ww11 
and ww17 as described [95]. Libraries were made and barcoded using the 
NextFlex barcoding system and library construction kits (Bio Scientific). Samples 
were sequenced by the IIGB Genomic Core facility, UC Riverside, using 
Illumina’s HiSeq2000 platform (51 bp reads). After filtering out low-quality reads 
using the default Illumina pipeline quality filter, we recovered 184.8 million reads 
representing an 18X average coverage. Reads were mapped onto the C. 
elegans genome sequence (WS201) and variants were identified using 
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MAQgene with default parameter setting except that minimum fraction of non-
wildtype reads was set to 0.8, minimum span of uncovered bases to report as 
uncovered region was set to 1 and maximum sum of error qualities was set to 
150 [96]. Mismatches were compared between all five mutants. Basepair 
changes common to all mutants were ignored, as these were likely present in our 
starting strain. Variants were validated by PCR and sequencing. Additional 
alleles were identified by PCR amplification followed by sequencing of targeted 
genes.   
RNAi Screen
RNAi screening was performed on 96-well plates using NGM agar containing 5 
mM IPTG. E. coli HT115 RNAi cultures were grown in LB containing 100 µg/mL 
ampicillin to log phase in 96-well deep well dishes. Bacteria were centrifuged and 
resuspended in 1/20 volume of M9. 10 mL of the resuspended cultures was 
added to the RNAi screening plates. For the Comamonas DA1877 condition 
screen, Comamonas DA1877 was grown overnight to saturation in LB, then 
sonicated and diluted 1/10 with LB containing 100 µg/mL ampicillin. 10 mL drops 
were added to each well of the E. coli HT115-RNAi seeded plates. VL749 
animals were synchronized by hypochlorite bleaching, washed in M9 media, and 
approximately 25 eggs were added to each well. After 60 hours animals reached 
the early adult stage and were visually screened for GFP expression. RNAi 
clones found to affect GFP in the first pass of the screen (856 clones) were re-
arrayed and retested four times. 554 genes retested at least 2 out of 4 times and 
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were re-arrayed again. These clones were tested three times for specificity using 
strain VL405, which contains an integrated Pmir-63::GFP construct [74]. 192 
genes did not affect Pmir-63::GFP in any of the three tests and were considered 
specific for Pacdh-1::GFP. All final hits were sequence-verified. 
Mutant Validation
nhr-68(gk708), sams-1(ok2946), cbl-1(ok2954), mce-1(ok243), pcca-1(ok2282), 
metr-1 (ok521) , ZK669.4 (ok3001), sams-5 (gk147), nhr-10 (tm4695) and hlh-11 
(ok2944) mutants were outcrossed three times to the wild type N2 strain, 
homozygosed, with the exception of the ok3001 allele, a deletion in the gene 
ZK669.4, which produced sterile homozygotes. Pictures of sterile 
ZK669.4(ok3001) homozygotes from heterozygous parents were taken and 
animals were retrospectively genotyped. RNA was isolated from the hlh-11 and 
sams-5 deletion mutant strains grown on E. coli OP50, E. coli HT115 or 
Comamonas DA1877 for qRT-PCR analysis. All outcrossed mutant strains were 
also crossed to VL749 and homozygosed.  
qRTPPCR
Animals were synchronized and grown on E. coli OP50, E. coli HT115, or 
Comamonas DA1877 and approximately 1000 adult animals were harvested for 
each condition. Animals were thoroughly washed in M9 buffer, and total RNA 
was isolated using Trizol (Invitrogen) followed by DNAseI treatment and cleanup 
using Qiagen RNeasy columns. cDNA was prepared from 1 mg of RNA using 
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oligo-dT and Mu-MLV enzyme (NEB). Primer sequences for quantitative RT-PCR 
(qRT-PCR) were generated using the GETprime database [97] and are listed in 
Table S5. qRT-PCR was performed in triplicate using the Applied Biosystems 
StepOnePlus Real-Time PCR system and Fast Sybr Green Master Mix 
(Invitrogen). Relative transcript abundance was determined using the ΔΔCt 
method, and normalized to averaged ama-1 and act-1 mRNA expression levels 
[98]. 
nCounter Analysis
RNA was extracted as described above. nCounter analysis was performed as 
per manufacturers instructions (Nanostring technologies) using 300 ng of total 
RNA, and expression between samples was normalized to ama-1 mRNA levels.  
Probes used are listed in Table 2.5. 
Functional Annotation
GO analyses were performed using David [99]. WormNet v.2 was used as 
described [100]. Genes found to affect Pacdh-1::GFP in the screens were 
subjected to functional categorization based on manual curation. Gene 
descriptions in WormBase were used to assign genes to categories when 
available, or the described function for the closest human homolog was used. If 
no functional annotation could be assigned to a gene, it was placed in the 
‘unknown’ category. If a gene’s described function was not within one of the 
major categories, it was placed in the ‘other’ category. Tissue expression was 
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assigned based on WormBase WS232 annotations and was categorized into 
intestinal, non-intestinal, and unknown groups. If the subset of tissues in which a 
gene is expressed included the intestine, it was placed in the intestinal group. If 
the tissue expression for a gene was described but did not include the intestine, it 
was placed in the non-intestinal group. If no expression patterns were described, 
it was placed in the unknown group. 
Metabolic Map
 
Annotations for C. elegans BCAA breakdown, methionine metabolism and the 
TCA pathway were obtained from the KEGG database [101] and from 
WormBase.  
 
Microarray Expression Profiling
Mutant animals were grown on Comamonas DA1877 on standard NGM plates 
for two generations prior to egg collection. Eggs were collected and synchronized 
in L1 stage and grown until they reached the gravid adult stage. Animals were 
washed twice in M9 buffer, pelleted by centrifugation and frozen at -80oC in 
Trizol. RNA was collected using Trizol extraction followed by DNAse I treatment 
and cleanup using RNeasy prep kit (Qiagen). Three biological replicates were 
prepared for each condition. Microarray expression profiling was performed by 
the Genomics Core facility at University of Massachusetts Medical School using 
C. elegans genome arrays (Affymetrix). The RMA method in the Affy package 
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from Bioconductor was used in R to summarize the probe level data and 
normalize the dataset to remove across-array-variation. Log transformed data 
were used in subsequent analyses. Moderated T statistics in Limma (Smyth et 
al., 2004) was used to calculate significance. Significance was determined using 
an adjusted p-value [102]. Changes in gene expression that were 2-fold (p < 
0.001) or greater were considered significantly changed. Microarray data was 
submitted to GEO (GSE43952). 
Starvation Experiments
 
Animals were first grown to L4 on E. coli OP50 bacteria. L4 animals were 
washed five times in M9, and then transferred to unseeded peptone-free NGM 
plates. After 24 hours, animals were collected and examined for GFP expression.   
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CHAPTER III: INTERSPECIES SYSTEMS BIOLOGY UNCOVERS
METABOLITES AFFECTING C. ELEGANS GENE EXPRESION AND
LIFE HISTORY TRAITS
 
Preface
 
This research chapter derives from work that I started shortly after submitting our 
2013 paper. We published this follow-up work in 2014, also in Cell, with the title 
“Interspecies systems biology uncovers metabolites affecting C. elegans gene 
expression and life history traits.” In this work, I am the first author, Lesley 
MacNeil is the second author, and the others on the paper are Ashlyn Ritter, 
Safak Yilmaz, Adam Rosebrock, Amy Caudy, and Marian Walhout. 
 Lesley MacNeil generated and screened the transposon-based 
Comamonas mutant library, and contributed Figure 3.1b, and Table 3.1. Safak 
Yilmaz analyzed the Comamonas whole-genome sequencing data and 
assembled the genome, and contributed Figure 3.2a. Adam Rosebrock and Amy 
Caudy developed the mass spec methods for measuring Ado-Cbl and Me-Cbl 
from bacteria, and generated the data that went into Figure 3.4a. Ashlyn Ritter 
performed the lifespan assays and is responsible for Figure 3.8a. 
Abstract
Diet greatly influences gene expression and physiology. In mammals, 
elucidating the effects and mechanisms of individual nutrients is challenging due 
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to the complexity of both the animal and its diet. Here we used an interspecies 
systems biology approach with Caenorhabditis elegans and two if its bacterial 
diets, Escherichia coli and Comamonas aquatica, to identify metabolites that 
affect the animal’s gene expression and physiology. We identify vitamin B12 as 
the major dilutable metabolite provided by Comamonas aq. that regulates gene 
expression, accelerates development and reduces fertility, but does not affect 
lifespan. We find that vitamin B12 has a dual role in the animal: it affects 
development and fertility via the methionine/S-Adenosylmethionine (SAM) cycle 
and breaks down the short-chain fatty acid propionic acid preventing its toxic 
buildup. Our interspecies systems biology approach provides a paradigm for 
understanding complex interactions between diet and physiology. 
Introduction
Our diet provides building blocks for development and reproduction, as 
well as energy to sustain daily cellular and organismal activities. Complex diets 
consist of macronutrients such as carbohydrates, fats and proteins, but also 
provide micronutrients such as vitamins that function as cofactors in metabolic 
reactions. In mammals, nutrients are provided not only by diet but are also 
synthesized by the gut microbiota [103]. A major challenge is to unravel the 
contributions of individual metabolites to cellular and organismal physiology, and 
to dissect the metabolic and genetic underpinnings of physiological responses to 
changing diets.  
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 The nematode C. elegans is an emerging model to study the effects of 
diet on life history traits such as developmental rate, fertility and aging [104-106]. 
C. elegans is a relatively simple model organism composed of fewer than 1000 
somatic cells. It lives in temperate climates around the globe and subsists on 
diets of various bacterial species growing on rotting vegetation. These bacteria 
also inhabit the C. elegans intestine to serve as its microbiota [107]. In the 
laboratory, C. elegans are grown monoxenically on E. coli OP50, but many other 
bacterial strains and species have been fed to worms as well [30, 104, 105, 108, 
109]. Bacteria supply C. elegans with metabolites that can greatly affect its life 
history traits. For instance, bacterially derived nitric oxide and folate extend and 
limit the lifespan of the animal, respectively [37, 110]. The effects of these 
metabolites were identified by a hypothesis-driven approach (nitric oxide) or 
serendipitously by a mutation in the bacteria (folate). Since both C. elegans and 
its bacterial diet are genetically tractable, we reasoned that this predator-prey 
combination could be used for the unbiased identification of nutrients that drive 
transcriptional and physiological responses in the animal. 
 We previously found that, relative to E. coli OP50, a diet of Comamonas 
DA1877 accelerates C. elegans development and decreases fertility and lifespan 
[105]. These physiological effects are accompanied by dramatic changes in gene 
expression [105]. For instance, the acyl-CoA dehydrogenase-encoding gene 
acdh-1 is repressed several hundred fold on the Comamonas DA1877 diet 
relative to E. coli OP50. We created transgenic animals harboring the acdh-1 
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promoter driving expression of the green fluorescent protein (GFP) to generate a 
transgenic “dietary sensor” strain with which the transcriptional response to the 
Comamonas DA1877 diet can be readily monitored in living animals [105]. 
Remarkably, the effects of Comamonas DA1877 on C. elegans gene expression 
and development persist even when these bacteria are mixed in small amounts 
with the E. coli OP50 diet, indicating that Comamonas DA1877 generates one or 
more dilutable compounds to which C. elegans responds. Using the dietary 
sensor strain, we identified a C. elegans network consisting of metabolic and 
regulatory genes that, when perturbed, interferes with the transcriptional 
response to Comamonas DA1877 [64].  
 Here, we used an interspecies systems biology approach to identify 
bacterial metabolites that affect C. elegans gene expression and life history traits. 
We performed genetic screens in E. coli and Comamonas to identify bacterial 
genes that, when mutated, result in aberrant repression or activation of Pacdh-
1::GFP in C. elegans. We performed a secondary metabolite screen by 
supplementing 25 candidate metabolites to Pacdh-1::GFP animals. Eight 
compounds activated the dietary sensor, including branched chain amino acids, 
threonine and propionic acid. Two compounds repressed the sensor – methyl-
cobalamin (Me-Cbl) and adenosyl-cobalamin (Ado-Cbl), the two biologically 
active forms of vitamin B12. We demonstrate that vitamin B12 is generated by 
Comamonas DA1877 but not by E. coli, and that it drives many of the gene 
expression and physiological changes in C. elegans induced by the Comamonas 
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diet. Interestingly all eight activating metabolites are closely connected in the C. 
elegans metabolic network to the two enzymes that require vitamin B12 as a 
cofactor. We find that vitamin B12 fulfills two important physiological roles in C. 
elegans: it regulates development through the synthesis of the major methyl 
donor SAM, and alleviates toxic buildup of the short-chain fatty acid propionic 
acid. Our interspecies systems biology approach provides a powerful paradigm 
for gaining insight into the complex interactions between diet, metabolic 
regulation and physiology. 
Results
Genetic Screens in Bacterial Diets
We previously determined that Comamonas DA1877 bacteria must 
produce a dilutable compound to which C. elegans responds with altered gene 
expression programs, accelerated development, reduced fertility and reduced 
lifespan [105]. We reasoned that we could discover bacterial metabolites that 
affect C. elegans by identifying bacterial genes involved in the generation, 
processing or transport of these small molecules. We used the C. elegans 
Pacdh-1::GFP dietary sensor as a reporter for diet-induced gene expression 
changes: GFP expression is high when the animals are fed E. coli OP50, but 
barely detectable when they are fed Comamonas DA1877. We performed 
genetic screens in each of these bacteria to identify mutant strains that, when fed 
to C. elegans alter GFP expression. 
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 First, we fed dietary sensor animals the Keio E. coli BW25113 collection, 
which contains deletion mutants for 3,985 of the 4,290 protein-coding genes [38]. 
We visually examined whether GFP expression was decreased or increased 
relative to animals fed the wild type strain (Figure 3.1a). In total, 70 mutant E. 
coli strains decreased GFP expression, and seven caused an increase compared 
to the parent strain (Table 3.1). Second, we performed a transposon-based 
mutagenesis screen of Comamonas DA1877 bacteria (Figure 3.1b). Using a 
non-replicating transposon, we generated 5,760 Comamonas DA1877 mutants 
each with a single transposon insertion. Five mutant Comamonas DA1877 
strains failed to repress GFP expression when fed to the sensor strain.  
 To facilitate the mapping of transposon insertions and identification of the 
disrupted genes, we sequenced the Comamonas DA1877 genome and 
annotated protein-coding sequences and RNA genes (Figure 3.2a). Since there 
was no systematic report on the taxonomic identity of Comamonas DA1877 
before this study, we first used the single 16S rRNA gene to identify this strain at 
the species level as Comamonas aquatica, and we will henceforth refer to 
Comamonas DA1877 as Comamonas aq. DA1877.  
 We reasoned that bacterial mutants identified affect C. elegans gene 
expression due to either the buildup or reduction in particular metabolites. A total 
of 77 E. coli and 5 Comamonas aq. DA1877 genes (Table 3.2) were identified in 
the bacterial screens. We focused on bacterial genes encoding metabolic 
enzymes, transporters, and transcription factors known to regulate metabolic 
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operons. Mapping these genes onto bacterial metabolic networks revealed that 
perturbation of several different pathways affected GFP expression in C. elegans 
(Figure 3.1c). For instance, mutations in enzymes from E. coli purine 
metabolism, propionic acid metabolism, the TCA cycle, and the biosynthesis of 
siderophores (iron scavengers) decreased dietary sensor activity. Conversely, E. 
coli and Comamonas mutations in branched chain amino acid biosynthesis and 
vitamin B12 biosynthesis/import resulted in increased C. elegans dietary sensor 
activity. 
A Metabolite Screen in C. elegans Identifies Vitamin B12 as a Candidate Comamonas4
Provided Molecule
We selected a subset of metabolites implicated by the bacterial screens 
for use in a secondary screen in which their effect on the C. elegans dietary 
sensor was tested by direct supplementation to either diet. We focused on 18 
metabolites implicated by bacterial genes encoding metabolic enzymes, 
transporters, and transcription factors known to regulate metabolic operons. We 
included 7 additional metabolites that were implicated from our earlier C. elegans 
genetic screens [64]. We supplemented the metabolites at various 
concentrations to the Pacdh-1::GFP sensor strain fed either bacterial diet (Figure 
3.3a). Six metabolites caused mild, dose-dependent increases in GFP 
expression when supplemented to the Comamonas aq. DA1877 diet, including 
the amino acids valine, isoleucine, threonine and glycine, as well as 
homocysteine and vitamin B6. Two metabolites, α-ketobutyrate and propionic 
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acid, more dramatically increased GFP expression when supplemented to 
Comamonas aq. DA1877 and also further increased GFP expression on the E. 
coli OP50 diet (Figure 3.3b, Table 3.3). 
 Only two metabolites mimicked the strong repressive effect of the 
Comamonas aq. diet on the Pacdh-1::GFP sensor when supplemented to E. coli 
OP50: the two biologically active forms of vitamin B12, Ado-Cbl Me-Cbl (Figure 
3.3c). Vitamin B12 is an attractive candidate to be the dilutable molecule 
produced by Comamonas aq. DA1877 [105] for several reasons. First, two of five 
Comamonas aq. DA1877 genes identified in the transposon screen encode 
vitamin B12 biosynthetic enzymes (cbiA and cbiB, Table 3.2 and Figure 3.2b). 
Second, vitamin B12 was also implicated by the E. coli deletion collection screen, 
even though they do not synthesize this cofactor (see below). A deletion in tonB, 
which encodes a protein required for vitamin B12 import [111], resulted in even 
greater levels of GFP expression when fed to the sensor strain (Figure 3.2c). 
Third, Ado- and Me-Cbl were the only repressors identified in the chemical 
screen, and both robustly repress Pacdh-1::GFP in low (nM) doses. This fits with 
the observation that mixing small amounts of the Comamonas aq. DA1877 diet 
into the E. coli OP50 diet is sufficient to exert gene expression and physiological 
changes [29]. Finally, mutations in the two C. elegans enzymes that use vitamin 
B12 interfere with the transcriptional response to the Comamonas aq. DA1877 
diet [64]. Vitamin B12 is an essential nutrient for most animals, but is only 
synthesized by some species of bacteria [112]. It is used as a cofactor by the 
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same two enzymes in all vitamin B12-dependent animals: methylmalonyl-CoA 
mutase (MUT; MMCM-1 in C. elegans), which is involved in propionyl-CoA 
breakdown, and methionine synthase (MS; METR-1 in C. elegans), which is 
involved in the methionine/SAM cycle. Methylmalonyl-CoA mutase uses Ado-Cbl 
whereas methionine synthase uses Me-Cbl (Figure 3.2d). We previously found 
that both of these vitamin B12-dependent enzymes, as well as others in their 
respective pathways, are required for Comamonas DA1877-induced gene 
expression changes [64]. Taken together, these results suggest that vitamin B12 
may be the dilutable molecule provided by the Comamonas aq. DA1877 diet that 
represses Pacdh-1::GFP. 
Vitamin B12PProducing Bacteria Repress Pacdh41::GFP
Our results predict that vitamin B12 levels are dramatically higher in the 
Comamonas aq. DA1877 than the E. coli OP50 diet. To directly compare the 
amounts of vitamin B12 we measured Ado-Cbl by mass spectrometry. Ado-Cbl 
levels are much higher in Comamonas aq. DA1877 than E. coli OP50 (Figure 
3.4a), but are reduced to background in the Comamonas aq. cbiA mutant, 
indicating that this mutant indeed fails to synthesize vitamin B12. 
 We fed additional bacterial species to Pacdh-1::GFP dietary sensor 
animals and correlated their effect on GFP expression with the presence or 
absence of a vitamin B12 biosynthesis pathway. Four of these seven bacterial 
species have the capacity to synthesize vitamin B12 and three do not (Figure 
3.4b). We found that the presence or absence of a vitamin B12 biosynthetic 
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pathway in the bacterial diet correlates perfectly with the repression or activation 
of the acdh-1 promoter in C. elegans, respectively (Figure 3.4b).  
Vitamin B12 Processing and Utilization System is Required For Its Affects on Pacdh4
1::GFP
Vitamin B12 repressed GFP expression equally well whether 
supplemented to live or UV-killed E. coli OP50 diets, indicating that its effects do 
not depend on E. coli modification or metabolism (Figure 3.5a). We wondered 
why Ado-Cbl and Me-Cbl repress the dietary sensor equally well (Figure 3.3). 
From studies of human cobalamin deficiency disorders, it is known that after 
vitamin B12 is imported into the cell, it is stripped of its upper axial ligand, 
undergoes several processing steps, is modified into Ado-Cbl and Me-Cbl, and 
distributed to the two enzymes that use it (Figure 3.5b). Our supplementation 
experiments likely cannot discriminate between individual effects of these two 
forms of vitamin B12 because they can be interconverted. We wondered whether 
vitamin B12 processing and/or distribution in C. elegans are required for its 
repressive effect on Pacdh-1::GFP. In our previous C. elegans genetic screens, 
we did not retrieve any vitamin B12 import and processing genes [64], potentially 
due to inherently high false negative rates in RNA interference (RNAi) screens 
[7]. We predicted C. elegans vitamin B12 processing genes based on homology 
with known human genes (Figure 3.5b). RNAi of each of two genes tested, mtrr-
1 and Y76A2B.5, resulted in failure of both Me-Cbl and Ado-Cbl to repress the 
dietary sensor (Figure 3.5c). This indicates that supplemented vitamin B12 must 
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be properly processed and regenerated into its active forms within C. elegans to 
repress Pacdh-1::GFP. 
We previously found that enzymes in propionyl-CoA breakdown and the 
methionine/SAM cycle are required for the repressive effect of the Comamonas 
aq. DA1877 diet on the dietary sensor [64]. Thus, one would predict that these 
enzymes are also required for the repressive effects of vitamin B12 
supplementation. We used two deletion mutants in each of these pathways to 
test whether they are also involved in mediating the response to vitamin B12. 
Indeed supplemention of vitamin B12 to either propionyl-CoA breakdown or 
methionine/SAM cycle mutants failed to repress acdh-1 promoter activity. 
(Figure 3.5d). Taken together, vitamin B12 processing/distributing genes and 
intact vitamin B12-dependent metabolic pathways are required for the effect of 
this cofactor on C. elegans. 
Propionic Acid Can Override Vitamin B12 to Activate the Sensor
Vitamin B12 represses the dietary sensor, while vitamin B6, 
homocysteine, glycine, threonine, isoleucine, valine, α-ketobutyrate and 
propionic acid activate the acdh-1 promoter (Figure 3.3a). Interestingly, the 
breakdown of each of these amino acids as well as α-ketobutyrate and propionic 
acid involves conversion to propionyl-CoA (Figure 3.6a). Vitamin B6 functions as 
a cofactor in two reactions that lead to the production of propionyl-CoA (Figure 
3.6a). Since vitamin B12 increases flux through the propionyl-CoA breakdown 
pathway, we hypothesized that the balance between vitamin B12 and propionyl-
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CoA levels may be the driving force controlling acdh-1 promoter activity. To test 
this hypothesis, we performed a chemical epistasis experiment and found that 
excess propionic acid can override the repressive effects of vitamin B12 on the 
dietary sensor in a dose-dependent manner (Figure 3.6b). This suggests that the 
effects of vitamin B12 on the acdh-1 promoter may depend on its capacity to 
repress the buildup of an activator, propionic acid. 
Vitamin B12 Mimics Broad Comamonas aq. DA1877 Mediated Gene Expression
Changes
The Comamonas aq. DA1877 diet affects the expression of many C. 
elegans genes, including acdh-1 [105]. To assess whether vitamin B12 can elicit 
similar broad effects on gene expression, we used quantitative RT-PCR (qRT-
PCR) to determine relative expression levels of 14 representative Comamonas-
downregulated genes and 14 representative Comamonas-upregulated genes in 
wild type animals fed E. coli OP50 with or without three doses of supplemented 
Me-Cbl or Ado-Cbl. All but one of the genes tested changed in expression on the 
Comamonas aq. DA1877 diet as described previously. Most of the Comamonas-
downregulated genes were also downregulated when animals were fed E. coli 
OP50 supplemented with either form of vitamin B12 (Figure 3.6c). Likewise, 
most Comamonas-upregulated genes were also activated by supplementation of 
vitamin B12 (Figure 3.6c). Thus, vitamin B12 supplementation to the E. coli 
OP50 diet induces similar gene expression changes as those elicited by the 
Comamonas aq. DA1877 diet. 
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 Six vitamin B12-downregulated genes, including acdh-1, were upregulated 
in response to propionic acid (Figure 3.6c). Further, propionic acid could 
override the repressive effect of vitamin B12 on these genes. Interestingly, a 
subset of the vitamin B12-downregulated genes did not respond to propionic 
acid. A similar trend was observed among the vitamin B12-activated genes; while 
some responded to propionic acid, others did not. Therefore, we determined that 
there are at least two classes of vitamin-B12 responsive genes: those that 
respond to propionic acid (hereafter referred to as type 1) and those that do not 
(type 2).  
Vitamin B12 Accelerates C. elegans Developmental Rate and Egg Laying Timing and
Requires the Methionine/SAM Cycle
Since vitamin B12 mimics the effects of the Comamonas aq. DA1877 diet 
on C. elegans gene expression, we next tested whether it also mimics the 
accelerated development, reduced fertility and accelerated aging induced by this 
bacterial diet [105]. Vitamin B12 supplementation affected neither the mean nor 
the maximum lifespan of C. elegans (Figure 3.8a). This indicates that another 
factor must be responsible for the Comamonas aq. DA1877 effect on aging, 
which is in agreement with the observation that a diet consisting of E. coli OP50 
supplemented with a small amount of Comamonas aq. DA1877 does not shorten 
lifespan [105]. 
Addition of vitamin B12 to the E. coli OP50 diet did accelerate 
development, although it did not fully recapitulate the extent of developmental 
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rate increase elicited by the Comamonas diet (Figure 3.7a). This indicates that 
additional growth enhancing bacterial factors may be provided by Comamonas. 
Propionic acid supplementation to the E. coli OP50 diet slowed C. elegans 
development, and supplementation of both propionic acid and vitamin B12 
resulted in intermediate growth rates (Figure 3.7b). Based on this observation 
we hypothesized that propionic acid levels may dictate developmental rate: low 
concentrations caused by high vitamin B12 would accelerate development, 
whereas high propionic acid levels that occur when vitamin B12 is limiting would 
slow development. To test this hypothesis, we measured developmental timing in 
four metabolic gene mutants, two from each vitamin B12-dependent pathway: 
Δmce-1 and Δpcca-1 from propionyl-CoA metabolism and Δmetr-1 and Δsams-1 
from the methionine/SAM cycle. When fed E. coli OP50, all four mutants 
exhibited slow growth compared to wild type animals (Figure 3.7c). Surprisingly, 
supplementation of vitamin B12 accelerated development in Δmce-1 and Δpcca-1 
mutant animals, but failed to increase developmental rate in Δmetr-1 and Δsams-
1 mutants (Figure 3.7c). Thus, vitamin B12-induced developmental acceleration 
requires a functional methionine/SAM cycle, but not the propionyl-CoA 
breakdown pathway. Δmce-1 and Δpcca-1 mutants fail to catabolize propionyl-
CoA [113], likely resulting in a buildup of propionic acid. Neither Δmce-1 nor 
Δpcca-1 mutants can break down propionic acid even when vitamin B12 is 
present; yet supplementation of this cofactor does accelerate development in 
these mutants. These data suggest that the levels of propionic acid are not the 
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driving force behind developmental rate, but rather that development is 
accelerated via the methionine/SAM cycle, as a result of buildup or lack of 
specific metabolites therein. 
To further test this model, we first focused on metr-1 (methionine 
synthase), which converts homocysteine to methionine by using vitamin B12 as a 
cofactor. In this reaction, 5-methyl-tetrahydrofolate is also converted to the 
biologically active form of folate, tetrahydrofolate (Figure 3.6a). Loss of METR-1 
function can be caused either by a mutation in the corresponding gene or as a 
result of vitamin B12 deficiency. In humans, loss of the corresponding enzyme 
leads to depletion of tetrahydrofolate and methionine, and buildup of 
homocysteine. Folate supplementation (which is converted to tetrahydrofolate in 
vivo) did not rescue the slow growth of Δmetr-1 mutants (Figure 3.7d). Thus, 
tetrahydrofolate depletion is not a primary cause of developmental rate reduction. 
Methionine supplementation, on the other hand, largely rescued the 
developmental rate defect of Δmetr-1 mutants (Figure 3.7d). Interestingly, 
methionine supplementation did not accelerate development of Δsams-1 mutant 
animals, which are impaired in converting methionine to SAM (Figure 3.7d) [89]. 
This suggests that the developmental acceleration by methionine depends on its 
conversion to SAM. Taken together, these data suggest that vitamin B12 
accelerates C. elegans development primarily through its role as a cofactor in the 
methionine/SAM cycle, rather than in propionyl-CoA breakdown. However, 
excess propionic acid slows development, which is likely due to toxic effects. 
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Supplementing E. coli with vitamin B12 reduced total brood size and 
therefore mimics the Comamonas aq. DA1877 diet in regard to this phenotype as 
well (Figure 3.8b). Both the Comamonas aq. DA1877 diet and vitamin B12 
supplementation altered the dynamics of egg laying; animals laid almost all of 
their eggs (93% and 96% respectively) within the first two days. In contrast, 
animals fed E. coli OP50 laid only 70% in the first two days (Figure 3.8c). This 
vitamin B12-induced shift to early egg laying was still observed in Δpcca-1 
mutants, but the effect was lost in Δmetr-1 mutant animals (Figure 3.8b). 
Together, these results indicate that vitamin B12 both accelerates development 
and shifts egg-laying dynamics via its role in the methionine/SAM cycle. 
Vitamin B12 Protects Against Propionic Acid Toxicity and Requires the PropionylPCoA
Breakdown Pathway
The developmental acceleration induced by vitamin B12 did not rely on its role in 
propionyl-CoA breakdown, however vitamin B12 did prevent some of the 
developmental deceleration induced by high doses of propionic acid (Figure 
3.7b). At such high doses, propionic acid is toxic to the animal (Figures 2A, 6A). 
We asked whether vitamin B12 supplementation could alleviate the toxic effects 
of excess dietary propionic acid in wild type and Δpcca-1 mutant animals. Vitamin 
B12 increased tolerance to propionic acid in wild type animals, but not in Δpcca-1 
mutant animals, which are much more sensitive to propionic acid 
supplementation in general (Figure 3.9a). This is in agreement with the notion 
that animals lacking pcca-1 accumulate propionic acid and cannot utilize vitamin 
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B12 to metabolize it. Interestingly, wild type animals fed Comamonas aq. 
DA1877 are much more resistant to propionic acid than those fed E. coli OP50 
supplemented with 64 nM vitamin B12 (Figure 3.9a). This indicates that 
Comamonas aq. DA1877 may provide additional compounds that alleviate 
propionic acid toxicity, or that these bacteria metabolize more propionic acid, 
thus lowering the effective concentration delivered to the animal. 
We wondered whether loss of metr-1 would also increase sensitivity to 
propionic acid toxicity. Surprisingly, Δmetr-1 mutants tolerated excess propionic 
acid slightly better than wild type animals, although this difference was lost when 
vitamin B12 was in ample supply (Figure 3.9b). When vitamin B12 is limiting it is 
conceivable that MMCM-1 and METR-1 compete for this cofactor. As a result, 
MMCM-1 might be able to utilize more of the vitamin B12 pool for the breakdown 
of propionic acid when METR-1 is absent.  
Transcription of acdh-1 is strongly activated in response to propionic acid 
supplementation, vitamin B12-deficient diets, or mutations in any of the four 
enzymes required for vitamin B12-dependent propionic acid breakdown. We 
wondered what the physiological role of this activation could be, and reasoned 
that acdh-1 may function in response to propionic acid buildup, perhaps to help 
dampen its toxic effects. We tested the sensitivity of Δacdh-1 mutants to 
propionic acid and found that they are much more sensitive than wild type 
animals (Figure 3.9b). Unlike Δpcca-1 mutants, however, Δacdh-1 mutants 
survived better on propionic acid when vitamin B12 was supplemented to the 
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diet. This is likely because, unlike in Δpcca-1 mutants, the vitamin B12-
dependent propionyl-CoA breakdown pathway is still intact in Δacdh-1 mutant 
animals. Taken together, type 1 vitamin B12 response genes that are activated 
by propionic acid may help to rewire flux through the metabolic network, thereby 
enabling the breakdown, excretion, or conversion of this metabolite, or alleviating 
its toxic effects indirectly. 
Conclusions
Using an interspecies systems biology approach with C. elegans and two of its 
bacterial diets, we uncovered metabolites that affect gene expression and life 
history traits. We identified vitamin B12 as the major dilutable compound 
produced by Comamomas aq. DA1877 that regulates gene expression, 
accelerates development and affects fertility [105]; this study). Further, we 
determined that the balance between vitamin B12 and propionyl-CoA is likely the 
main driving force in the regulation of type 1 vitamin B12-response genes. This 
finding may reconcile a puzzling observation, namely that both vitamin B12 
supplementation and starvation repress the dietary sensor [105]. How can 
supplementation of a compound and the absence of a compound have the same 
effect? In rats, starvation lowers levels of short chain fatty acids, including 
propionic acid, as animals catabolize their fat stores [114]. In worms starvation 
and vitamin B12 supplementation may have the same repressive effect on the 
dietary sensor by reducing the levels of propionyl-CoA. 
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 We identified different physiological functions for the two vitamin B12-
dependent pathways in C. elegans: the methionine/SAM cycle affects 
development and fertility, whereas the propionyl-CoA breakdown pathway 
mitigates propionic acid-induced toxicity (Figure 3.10). The observation that the 
methionine/SAM cycle affects development is compatible with the notion that this 
is an anabolic pathway that generates SAM, the major methyl donor used to 
modify proteins such as histones [115], and to synthesize phosphatidylcholine 
[89], which is vital for the production of cell membranes during development. 
Vitamin B12 represses acdh-1 expression at the level of transcription, 
though it is unclear whether it acts directly or indirectly. We previously identified 
several nuclear hormone receptors that control the response of the acdh-1 
promoter to nutritional and metabolic conditions [64, 105]. Fat-soluble vitamins A 
and D are direct ligands for nuclear hormone receptors [116]. The C. elegans 
genome encodes 274 nuclear hormone receptors [117]. It is tempting to 
speculate that vitamin B12 directly interacts with one or more of these nuclear 
hormone receptors. However, our data indicate that vitamin B12 can only repress 
Pacdh-1 when it can efficiently be used to break down propionyl-CoA because 
metabolic perturbations that block propionyl-CoA breakdown, or supplementation 
of excess propionic acid to wild type animals can override the repressive effect of 
vitamin B12 on acdh-1 expression. We speculate that propionic acid may directly 
interact with one or more nuclear hormone receptors to regulate type 1 vitamin 
B12-response genes. 
108
 C. elegans is likely to encounter many different bacterial food sources in 
the wild [107]. Not all bacterial species synthesize vitamin B12 and C. elegans 
may have evolved an optimal gene expression program to help the animal cope 
with diets low in vitamin B12-producing bacteria. One consequence of this gene 
expression program may be metabolic rewiring; the expression levels of several 
metabolic genes predicted to function in vitamin B12-dependent pathways are 
sensitive to dietary vitamin B12 content [64, 105]. Turning various enzymes on or 
off at the level of gene expression may help to optimize metabolic flux. acdh-1 
expression is induced dramatically when vitamin B12 levels are low and 
propionic acid levels are high. While the exact metabolic functions of the ACDH-1 
enzyme are unknown, we suspect that it may serve to re-route flux around 
propionyl-CoA within the metabolic network when vitamin B12 is limited to 
prevent toxic buildup of propionic acid in the animal. This notion is supported by 
our observation that Δacdh-1 mutants are sensitive to propionic acid toxicity.  
Our findings suggest that C. elegans development, as it has been studied 
in the laboratory for decades using E. coli OP50, which is low in vitamin B12, 
only reflects one natural state. It will be interesting to study other characteristics 
of the animal such as behavior, mating and movement under ample vitamin B12 
conditions.  
 Vitamin B12 deficiencies in humans can have severe impacts on health, 
causing anemias and neuropathies, as well as low birth weight, developmental 
retardation and defects in cognitive abilities in children of vitamin B12-deficient 
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mothers [118]. Such deficiencies can lead to propionic and methylmalonic 
acidemias, homocystinuria, methionine/SAM deficiency or a combination thereof, 
and it is not yet fully understood which of these metabolic imbalances lead to 
physiological and pathological consequences in humans. Each of these different 
diseases can also be caused by inborn errors in metabolic genes; for instance 
propionic acidemia is caused by mutations in the human ortholog of pcca-1 [119]. 
Altogether, the interspecies paradigm we present provides a model to further 
characterize vitamin B12-dependent processes, and may provide a platform for 
the development of dietary or drug treatments to vitamin B12-related 
deficiencies. 
 Vitamin B12 is an essential cofactor in mammals and C. elegans [120], but 
is not used at all by plants, yeast or many insect species. The uneven distribution 
of vitamin B12 use among eukaryotes is interesting, as is the uneven distribution 
of vitamin B12 biosynthetic capability among bacterial species. Considering that 
many species of enteric bacteria can synthesize this essential vitamin suggests 
that the chemical outsourcing of vitamin B12 production may be an important 
keystone of a mutually beneficial relationship between gut microbiota and host 
[121-123]. The microbiota greatly affects its host’s metabolism [124]. For 
instance, bacteria in the gut break down dietary fiber, which results in the 
production of short-chain fatty acids such as propionic acid that are absorbed by 
intestinal epithelia and used to generate energy [119]. Altogether, the microbiota 
facilitate digestion, affect xenobiotic response to drugs and other chemicals [125, 
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126], and are critically important in the immunological defense [127]. The fact 
that both C. elegans and its bacterial diets are genetically tractable provides a 
powerful system to further unravel the complex interactions between diet, 
microbiota, metabolism, physiology and pathology, and the molecular 
mechanisms involved. 
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Figures
 
Figure 3.1 – Bacterial Screens  
(A) Diagram of the Keio E. coli deletion collection screen. (B) Diagram of 
Comamonas DA1877 transposon mutagenesis screen. (C) Network of 
metabolites implicated by bacterial screens. SAICAR = 5-Amino-4-imidazole-N-
succinocarboxamide ribonucleotide; [acp] = acyl carrier protein. 
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Table 3.1 – E. coli Deletion Mutants that Affect Pacdh41::GFP 
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Table 3.2 – Comamonas aq. DA1877 Mutants Identified in Transposon Screen.
Related to Figure 3.1 and Figure 3.2. 
 
 
Transposon-disrupted 
gene Function 
cbiA/cobB EC 6.3.5.9/6.3.5.11; cobyrinic acid a,c-diamide synthase 
cbiB EC 6.3.1.10; adenosylcobinamide-phosphate synthase 
threonine dehydratase EC 4.3.1.19; converts threonine to 2-oxobutanoate and ammonia 
RND efflux system protein unknown 
hypothetical protein with 
helix-turn-helix unknown 
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Figure 3.2 – Comamonas aq. DA1877 Genome Assembly and Vitamin B12
Import/Biosynthesis Mutants.  
(A) Genome sequencing and analysis for Comamonas DA1877. The circle 
represents the assembled genome sequence with segments showing contig 
lengths. Half of the assembled genome resides in contigs of 156.5 kb or longer. 
The assembly served as the input to the RAST server for the annotation of 
coding sequences and RNA genes, which in turn was used by the model SEED 
for the reconstruction of metabolic pathways including vitamin B12 biosynthesis. 
(B) DIC and fluorescence images of Pacdh-1::GFP animals fed E. coli OP50, 
Comamonas aq. DA1877, and five Comamonas aq. DA1877 mutants identified in 
the transposon screen that increase GFP expression. Inset images were taken at 
10x exposure time. (C) DIC and fluorescence images of Pacdh-1::GFP animals 
fed the Keio E. coli parent strain (left) or the Keio E. coli ΔtonB mutant (right). 
The mutant confers increased GFP expression in C. elegans. (D) Left: chemical 
structure of Me-Cbl and diagram of the Me-Cbl-dependent reaction catalyzed by 
methionine synthase (metr-1). Right: chemical structure of Ado-Cbl and diagram 
of the Ado-Cbl-dependent reaction catalyzed by methylmalonyl-CoA mutase 
(mmcm-1). Hcy = homocysteine; 5-Me-THF = 5-methyl-tetrahydrofolate; THF = 
tetrahydrofolate; L-Met = L-methionine; Me-malonyl-CoA = methylmalonyl-CoA. 
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Figure 3.3 – Metabolite Screen  
(A) Effects of supplementing metabolites to Pacdh-1::GFP animals fed either 
Comamonas aq. DA1877 (left column) or E. coli OP50 (right column). Shades of 
green represent relative GFP expression. Numbers indicate metabolite 
concentrations (in mM). (B) Pacdh-1::GFP animals fed Comamonas aq. DA1877 
bacteria alone or supplemented with the indicated compounds that activate GFP 
expression. Exposure time is indicated in yellow. Exposure time for inset images 
is 400 ms. (C) Pacdh-1::GFP animals fed E. coli OP50 bacteria supplemented 
with the indicated compounds that repress GFP expression. Exposure time is 
indicated in yellow. Exposure time for inset images is 400 ms. 
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Figure 3.4 – Correlation Between Bacterial B12 Biosynthesis and Repression of Pacdh41::GFP
(A) Ado-Cbl content measured by mass spectrometry in indicated bacterial 
strains. The red line indicates background levels of Ado-Cbl in the bacteria-free 
control. (B) Correlation between vitamin B12 biosynthesis pathway presence and 
dietary sensor repression. Images of Pacdh-1::GFP animals fed various bacterial 
strains are located below a cartoon that indicates pathway status. Differences in 
exposure times for the inset images are indicated in yellow.  
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Figure 3.5 – Vitamin B12 Processing Genes and Dependent Pathways are Required for
Repression of Pacdh41::GFP.  
(A) DIC and fluorescence images of Pacdh-1::GFP animals fed live and UV-killed 
E. coli OP50 (left set of images) or live and UV-killed Comamonas aq. DA1877 
(right set of images). Addition of Ado-Cbl 64nM is sufficient to repress GFP 
expression on both living and killed E. coli OP50. Addition of 40mM propionic 
acid is sufficient to activate GFP expression on both live and killed Comamonas 
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aq. DA1877. (B) Cartoon of vitamin B12 processing and processes. Orange text 
indicates complementation groups of human genetic cobalamin deficiencies, 
black and purple indicate human and C. elegans genes, respectively, and red 
indicates different forms of vitamin B12 (Cbl). Question marks indicate vitamin 
B12 processing/distribution factors that have yet to be identified. (C) DIC and 
fluorescence images of Pacdh-1::GFP animals subjected to RNAi knockdown of 
mtrr-1 and Y76A2B.5 compared to control knockdowns, in the presence and 
absence of supplemented Me-Cbl or Ado-Cbl (64nM each). (D) DIC and 
fluorescence images of Pacdh-1::GFP animals in a wild type background 
compared to metabolic mutant backgrounds (Δmetr-1, Δsams-1, Δpcca-1 and 
Δmce-1) fed Comamonas aq. DA1877, E. coli OP50, or E. coli OP50 
supplemented with 64 nM Ado-Cbl or 64 nM Me-Cbl. 
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Figure 3.6 – Chemical Epistasis Between Vitamin B12 and Propionic Acid With Respect
to C. elegans Gene Expression
(A) Network of the two vitamin B12-dependent pathways. Metabolites are 
indicated in rectangles. Green metabolites activate the dietary sensor when 
supplemented to the bacterial diet. Genes encoding the metabolic enzymes 
involved are indicated with arrows between metabolites. Genes that, when 
mutated, activate the dietary sensor are indicated in red. Red hexagons – vitamin 
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B12; green hexagons – vitamin B6; blue indicates folate metabolism. 5-Me-THF 
= 5-methyltetrahydrofolate; THF = tetrahydrofolate, the biologically active form of 
folate. (B) Chemical epistasis of combined supplementation of Ado-Cbl and 
propionic acid on Pacdh-1::GFP dietary sensor animals fed the E. coli OP50 diet. 
(C) qRT-PCR of 14 Comamonas-upregulated and 14 Comamonas-
downregulated genes in wild type animals fed indicated diets and supplemented 
metabolites. PA = propionic acid. N2 = wild type animals. Changes in expression 
for each gene are plotted as log2 fold change compared to respective mRNA 
levels in wild type animals fed E. coli OP50 (first and third columns) or 
Comamonas aq. DA1877 (middle column). 
See Table 3.4 for qPCR primer sequences. 
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Primer Forward Seq Reverse Seq 
Comamonas-upregulated genes 
cbs-1 AACAAGTTCAACCCAGAAAGG TTGAAGCTTGACGAGTGGA 
acdh-8 TGTCATTTGAACTGTCCGA CATTTGGCACAAGAACGTC 
F15E11.12 AGTATGCTGGAAAGGATGGA TCCATTTGGCGAGTAGTCC 
grd-4 CAGAACACTACGATGTTAACGG CGGATGGAATACGAAGTTTGTC 
D1086.3 CGTGCAAAGACACCATGGAATG GAGCACGACCACAGAAGTCG 
gst-20 CTAGACAGCTCTTCGCCCTATCC GGCATTTGGCCAAAGGGC 
ech-1 CTGAGGCTAAGGCATTTGG CATTAGTCGATCCTTCGAACAG 
sodh-1 GCTGGAGTCAAGCTCATGAACTT
C 
CGATCGAACCCATAGTTCTGGATG 
Y53G8AM.5 GGAAGCAGCTACTACTCGT GTAGTCGAAGGCATTTCCC 
T24B8.5 TACACTGCTTCAGAGTCGTG CGACAACCACTTCTAACATCTG 
C32H11.4 GAATGGGCTCCGTATACCACCC GTCTGAACTGAAATCGGCCGC 
W110G11.3 GAGGCATGTGATAACCTTTTCGG
G 
GCTAGAGTGTTCTTCCGGAACC 
F54C8.1 GCATCAATGACCGACATCG TCGAGACCAATGTAGTCGG 
lipl-2 GCATTGGCACCGATTGGTG CGTACCAACCATCAAATTCGGGAG 
Comamonas-downregulated genes 
msra-1 GAAAGAAGCAATACCAATCTGC ATGTCTCCATGCTTGTCCT 
Y38F1A.6 GATATTCCGAACAATGCCAG TCCAAAGTCTCGCATATAACC 
acs-2 TCCGGATAAGGAGTTCTGTG ATTTGACGGACGTCATGGT 
folt-2 CTTTGAATAGTCAGGTGTACCC ATACATCGGTGAGTAGGAACG 
pmp-5 CGCATTCTACTTCATCTACCT TACGAATTCGCTCACTCTC 
F21C10.9 TGGCTTAAGAGGAGTCGTC CCCAATCTGTTTCAGATAAGTCTC 
nhr-114 ATTACAGCTATCGCCTCCAC GTTTGTAGGATGCAGCGAC 
Y110A7A.4 ACAATGTGTCAGTTCTATGTGG AACTCCGAGACCCATATCTC 
F32D8.12 AGGGCAACTTTATGGAAAGC TGTCGTGAATCCTCTTGCT 
acdh-1 GCAAATGCAGATCCTAGCC GTTTGTCTTCCTCCTTATCTACAG 
acdh-2 GATGATAATCTTGGAATGCGTGC 
CTTCAATAGCGTATTTGTATCCTTTTC
C 
ech-6 TCGGAGCAATTGTGATTACTG CGAACTCGTTATTGGTCATCTC 
F09F7.4 CACAATGGAGTATCGTCTCAC TTGTCAACGAGAATGGCTC 
cth-1 CACTTTGGAACTGATGCAGTC CATACTAATTGGTGGAACTACCTG 
 
Table 3.4 – qRTPPCR primers.
Related to Figure 3.6. 
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Figure 3.7 – Effects of Metabolite Supplementation on C. elegans Development
(A) Developmental progression of synchronized wild type populations of animals 
fed indicated diets and supplemented metabolites. The parental generation was 
cultivated on E. coli OP50. (B) Developmental progression of synchronized wild 
type populations of animals fed indicated diets and supplemented metabolites. 
PA = propionic acid. Vitamin B12 = 64 nM Ado-Cbl. The parental generation was 
cultivated on E. coli OP50. (C) Developmental progression of synchronized 
wild type and mutant populations of animals fed indicated diets and 
supplemented metabolites. 64 nM of each variant of vitamin B12 was used. (D) 
Developmental progression of synchronized wild type and mutant populations of 
animals fed indicated diets and supplemented metabolites. L-Met = 4 mM 
methionine. Folate = 56 mM. 
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Figure 3.8 – Vitamin B12 Affects C. elegans Egg Laying but not Lifespan.  
Related to Figure 3.7. (A) Lifespan analysis of wild type animals fed E. coli OP50, 
Comamonas aq., or E. coli OP50 supplemented with either 64 nM or 6.4 µM Ado-
Cbl or Me-Cbl. A representative lifespan experiment is shown at the top. The 
table summarizes mean and maximum lifespans from three combined 
experiments. (B) Three independent brood size measurements of wild type 
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animals fed E. coli OP50, Comamonas aq. DA1877, or E. coli OP50 
supplemented with 64 nM Ado-Cbl. (C) Percentage of total eggs laid in the first 
two days of adulthood by wild type animals fed E. coli OP50, Comamonas aq. 
DA1877, or E. coli OP50 supplemented with 64 nM Ado-Cbl. Included also is the 
percentage of total eggs laid in the first two days of adulthood by Δpcca-1 and 
Δmetr-1 mutants fed either E. coli OP50 or E. coli OP50 supplemented with 64 
nM Ado-Cbl. Vitamin B12 fails to shift egg laying in Δmetr-1 mutants.  
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Figure 3.9 – Effects of Vitamin B12 on Propionic Acid Toxicity  
(A) Toxicity analysis of incremental doses of propionic acid on wild type and 
Δpcca-1 mutant C. elegans in the absence and presence of 64 nM Ado-Cbl 
(B12). Mean +/- SEM is plotted from three combined experiments. (B) Percent 
survival of different C. elegans strains fed E. coli OP50 at two concentrations of 
propionic acid (PA) in the absence or presence of 64 nM Ado-Cbl. Mean +/- SEM 
is plotted from four combined experiments. 
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Figure 3.10 – Model  
Our findings demonstrate that the Comamonas aq. DA1877 diet provides high 
levels of vitamin B12, whereas the E. coli OP50 diet is low in this cofactor. 
Vitamin B12 acts through two different pathways: it lowers levels of propionyl-
CoA, thereby preventing propionic acid toxicity, and enables the synthesis of 
methionine and SAM, thereby accelerating development and reducing fertility. 
Methionine synthesis reduces levels of homocysteine and likely propionyl-CoA 
levels. Our data suggest that vitamin B12 may affect these processes by 
regulating the expression of different sets of genes (type 1 and type 2); some that 
respond oppositely to propionyl-CoA and others that are insensitive to this 
metabolite. 
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Experimental Procedures
C. elegans Strains
N2 (Bristol) was used as the wild type strain and animals were maintained as 
described at 20oC [90]. sams-1(ok2946), mce-1(ok243), pcca-1(ok2282), metr-
1(ok521) and acdh-1(ok1489) strains were provided by the C. elegans Gene 
Knockout Consortium and back-crossed as described [64]. We previously 
described the Pacdh-1::GFP strain (VL749) [105].   
Bacterial Strains
E. coli OP50, Serratia marcescens IGX2 and Comamonas aq. DA1877 were 
obtained from the CGC. Pseudomonas aeruginosa PA14 (gacA mutant) was a 
gift from Victor Ambros (UMMS), Corynebacterium glutamicum ATCC13032 and 
Comamonas testosteroni ATCC11996 were obtained from ATCC. 
Mycobacterium smegmatis MC2-155 was a gift from Chris Sassetti (UMMS). For 
the killed bacteria experiment, E. coli OP50 and Comamonas aq. DA1877 
cultures were grown to log phase in LB, then harvested and washed, irradiated 
with UV (254nm, 5 J/cm2), concentrated, and added to NGM plates.  
E. coli Deletion Collection Screen
Keio E. coli deletion collection clones (Thermo Scientific) were grown overnight in 
Luria Broth (LB) containing 50 mg/mL kanamyacin in 96-well deep well dishes. 
15 mL of this overnight culture was seeded onto 96-well nematode growth media 
(NGM) agar plates containing 50 mg/mL kanamyacin. Pacdh-1::GFP gravid 
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adults fed the Keio parent strain were bleached to harvest embryos, which were 
subsequently washed in M9 media and allowed to hatch overnight to synchronize 
the population by L1 arrest. Approximately 25 synchronized L1 animals were 
added to each well of the seeded plates. After incubating 48 hours at 20°C, 
animals were visually screened for GFP expression. Each plate from the Keio 
collection was screened twice, thus each E. coli gene was screened four times. 
Deletion mutants that affected GFP expression in at least two out of four 
experiments were considered hits. 
Comamonas aq. DA1877 TransposonPBased Mutagenesis Screen
 
Random insertions into the Comamonas aq. DA1877 genome were generated 
using a Mariner transposon introduced via conjugation with E. coli. Briefly, fresh 
cultures of E. coli SM10λpir+ carrying the pBTK30 transposon delivery vector 
[128] and Comamonas aq. DA1877 were scraped from plates and transferred to 
an LB plate where they were mixed together in a ratio of approximately 10:1 (E. 
coli : Comamonas). Bacteria were conjugated at 37°C for one hour, recovered 
from the plate, resuspended in LB and plated onto LB plates containing 10 µg/mL 
gentamycin and 100 µg/mL streptomycin to select for the transposon and against 
E. coli, respectively. Following overnight incubation, individual colonies were 
picked into 96 well plates and grown overnight at 37C in LB supplemented with 
10 µg/mL gentamycin. NGM plates were inoculated from overnight cultures and 
allowed to grow for 2-3 days at room temperature. Plates were then seeded with 
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approximately 20 Pacdh-1::GFP eggs prepared by hypochlorite bleaching, and 
GFP expression was examined in adult animals. Positive scoring wells were 
streaked for single colonies. A single colony was picked and used for re-testing 
and further characterization. In total, 5,760 colonies (60 96-well plates) were 
screened for their effect on GFP expression. 
 Transposon insertion sites were identified by arbitrary PCR or by cloning 
of genomic fragments into pUC19 and selecting for gentamycin-resistant 
colonies. Arbitrary PCR was performed as described in [129] with a few 
modifications. Two separate PCR reactions were performed for each mutant 
using one of ARB1 (GGCCACGCGTCGACTAGTACNNNNNNNNNNAGAG), or 
ARB3 (GGCCACGCGTCGACTAGTACNNNNNNNNNNGATAT) primers along 
with Rnd1-TnM30 (CACCGCTGCGTTCGGTCAAGGTTC). A second round of 
PCR was done using ARB Rnd2 (GGCCACGCGTCGACTAGTAC) and BTK30 
Rnd2 (CGAACCGAACAGGCTTATGTCAATTC) primers. Unique bands were gel 
purified and reamplified for sequencing. Target genes were identified by 
comparing sequences proximal to the transposon to the Comamonas aq. 
DA1877 genome using BLAST. 
Comamonas aq. DA1877 Genome Sequencing, Assembly, and Annotation
 
Bacterial pellets from a centrifuged Comamonas DA1877 culture were submitted 
to Genewiz, Inc. (South Plainfield, NJ) for DNA isolation and whole genome 
sequencing with Illumina-Miseq technology. A library of ca. 30.5 million short 
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reads (150-bp, paired-end) was obtained and de novo assembled using Edena 
[130], version 3.130110. The assembly resulted in an overall length of 3,956,064 
basepairs arranged in 83 contigs with N50=156,501 bp (i.e., 50% of the 
assembly was included in contigs of this size and greater). The genome 
sequence was annotated and analyzed using the SEED pipeline [131, 132]. First, 
contigs were uploaded to the rapid annotation using subsystem technology 
(RAST) server [133], which determined 3,665 protein-coding sequences and 96 
RNA genes. The web-based Bayesian classifier tool of Ribosomal Database 
Project [134] placed the 16S rRNA sequence in the Comamonas genus under 
Betaproteobacteria at 100% confidence level.  The SEQMATCH tool of the same 
website determined the nearest type strain as Comamonas aquatica [135] with a 
sequence similarity of 99.6%; no other type strain had a match with >99% 
similarity. A draft metabolic reconstruction was generated using the model SEED 
[132] for the systematic analysis of metabolic pathways.  
Vitamin B12 Biosynthesis Pathway Analysis
To determine the presence or absence of vitamin B12 biosynthesis pathway in 
bacterial species used in this study, we first gathered EC numbers from KEGG 
[136] and MetaCyc [137] for all reactions comprising this pathway. For 
Comamamonas aq. DA1877, we cross-referenced these EC numbers against all 
EC numbers annotated in the draft metabolic network reconstruction from SEED 
and determined which vitamin B12 biosynthesis enzymes were encoded in the 
genome. For other bacterial species, we determined the presence or absence of 
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vitamin B12 biosynthesis genes based on the same EC numbers, but used 
KEGG and Metacyc databases to guide annotation. If an EC number in the 
vitamin B12 biosynthesis pathway was annotated as present for a particular 
species in either or both of these databases, we called it present.  
Metabolite Screen
 
Metabolites were purchased from Sigma-Aldrich and dissolved in water to the 
maximum soluble concentration. Dilutions were made in water as indicated in 
Figure 3.3. For each stock solution, pH was adjusted to 6.0 with sodium 
hydroxide or hydrochloric acid. Stock solutions were added to NGM in various 
doses just prior to plate pouring. 
MassPSpectrometry
 
Bacterial strains were grown in NGM medium, with peptone supplied by 
American International Chemical. 30 mL bacterial cultures were centrifuged, 
washed twice with 50 mM sodium citrate buffer (pH = 7.2) and frozen at -80oC 
until extraction. Washed cells were extracted on a roller drum at 37oC for 3 hours 
using 3 mL of 100 mM sodium acetate buffer (pH = 4.0) containing 2 mg porcine 
pepsin (Sigma). The extract was clarified by centrifugation and purified using a 
gravity drip C18 100 mg column (Biotage). The column was preconditioned with 
3 mL methanol, followed by 3 mL water; following sample application, the column 
was washed with 3 mL water and eluted with 1.5 mL methanol. The samples 
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were dried down under vacuum and resuspended in water corresponding to 
0.096 OD600 units of cells per ml of solution.  
Instrumentation for LC-MS analysis was an Agilent UHPLC system, HTS 
PAL autosampler, and an Agilent 6490 QQQ using an Agilent Eclipse Plus 
phenyl-hexyl UHPLC column (2.1 x 100 mm, 1.8 um particle size). Mobile phase 
A was 20 mM ammonium formate with 0.1% formic acid in water.  Mobile phase 
B was 20 mM ammonium formate and 0.1% formic acid in methanol. The 
gradient was 0 min, 10% B, 0.5 min 33% B, 3 min 50% B, 3.1 min 90%B, 3.5 min 
90% B, 4 min 10%A, supplied throughout at 0.5 mL/min. The column 
temperature was maintained at 35oC and the autosampler at 4oC.  The injection 
loop volume as 2 ml. The QQQ was run in positive ionization mode. Instrument 
run parameters were: nebulizer pressure 20 psi, source gas temp 290 oC, source 
gas flow 13 LPM, sheath gas temp 400oC, sheath gas flow 12 LPM, capillary 
voltage 3000 V, nozzle voltage 1000V, high pressure funnel RF 190V, low 
pressure funnel RF 100V. Monitored parent/product ions (collision energy) was 
790.6/147.2 (50). Ado-Cbl was separated with a retention time of 2.3 minutes. 
Standards were purchased from Sigma-Aldrich and prepared fresh in water for 
analysis. 
RNAi Experiments
RNAi feeding clones were obtained from the ORFeome RNAi library [8]. E. coli 
HT115 strains expressing dsRNA directed against the C. elegans genes mtrr-1 
and  Y76A2B.5 and a control vector-only strain were grown in LB containing 100 
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µg/mL ampicillin to log phase, then concentrated and added to NGM agar plates 
containing 5 mM IPTG plus or minus Ado-Cbl or Me-Cbl. Pacdh-1::GFP embryos 
harvested by hypochlorite bleaching were added to the RNAi plates. Progeny of 
these RNAi-treated animals were transferred to fresh RNAi plates so that RNAi 
treatment could extend through an additional generation after which GFP was 
observed. 
qRTPPCR
Embryos from N2 wild type gravid adults grown on E. coli OP50 were harvested, 
washed and hatched overnight in M9 to synchronize the population. 
Synchronized L1s were added to plates containing various concentrations of Me-
Cbl or Ado-Cbl (both from Sigma), and/or propionic acid, seeded with E. coli 
OP50 or Comamonas DA1877. Animals were harvested for each condition when 
the majority of the population reached young adult stage. Total RNA was isolated 
using Trizol (Invitrogen), then purified of contaminating DNA by DNAseI 
treatment followed by cleanup using Qiagen RNeasy columns. cDNA was 
reverse-transcribed from RNA using oligo(dT)12-18 primer and Mu-MLV reverse 
transcriptase (NEB). Primer sequences for quantitative RT-PCR (qRT-PCR) were 
generated using the GETprime database [97] and are listed in Table 3.4. qRT-
PCR reactions were performed in triplicate using the Applied Biosystems 
StepOnePlus Real-Time PCR system and Fast Sybr Green Master Mix 
(Invitrogen). Relative transcript abundance was determined using the ΔΔCt 
method, and normalized to averaged ama-1 and act-1 mRNA levels [98]. 
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Developmental Rate, Fertility and Lifespan Assays
For all experiments, animals were grown at 20oC. We measured the 
developmental state of a population by synchronizing animals by L1 arrest in M9 
for 20 hr, then allowing animals to develop for 45 hours at 20oC under various 
dietary conditions. For L-methionine and folate supplementations, solutions (5 
mg/mL L-Met in water or 0.1 mg/mL folate in 20% ethanol) were added on top of 
plain NGM plates and dried prior to bacterial seeding. After 45 hours, ~35–80 
animals were mounted on agarose pads and visually categorized on a compound 
microscope into age groups based on the development of the vulva and germline 
as described [105]. 
 Brood sizes were determined by transferring 30 L4 animals onto individual 
plates containing E. coli OP50, Comamonas aq. DA1877, or E. coli OP50 
supplemented with 64 nM Ado-Cbl. Animals were transferred to new individual 
plates daily and the number of viable offspring on the plates was counted after 
hatching.  
 For the lifespan assays, ~125 L4 animals were transferred onto NGM 
plates containing 0.1 mg/ml FUDR, with or without vitamin B12, seeded with 
either E. coli OP50 or Comamonas aq. DA187. Animals were checked for body 
movement or pharyngeal pumping every two days. If no pumping was observed, 
animals were lightly tapped with a sterile platinum wire, and if animals failed to 
respond to the touch stimulus they were considered dead. 
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Propionic Acid Toxicity Assay
Approximately 100 starved L1 animals were placed on NGM media with 
increasing concentrations of propionic acid (pH 6.0). After 48 hours, live animals 
were counted. Each dose of propionic acid was analyzed in triplicate. 
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CHAPTER IV: A PROPIONATE BREAKDOWN SHUNT IN C.
ELEGANS ENABLES SURVIVAL ON LOW B12 DIETS
 
Preface
 
This research chapter derives from work that I started shortly after 
submitting our 2014 paper detailing the discovery that bacterially-provided 
vitamin B12 represses acdh-1 expression. This chapter is an adaptation of a 
manuscript that is in the process of being submitted for publication, with the title 
“A propionate breakdown shunt in C. elegans enables survival on low B12 diets.” 
In this work, I am the first author, Viridiana Olin-Sandoval is the second author, 
and the others on the paper are Michael Hoy, Chi-Hua Li, Timo Louisse, Vicky 
Yao, Amy Holdorf, Olga Troyanskaya, Markus Ralser, and Marian Walhout. 
 Viridiana Olin-Sandoval and Markus Ralser developed the mass spec 
protocols for measuring 3-hydroxypropionate and propionyl-CoA in C. elegans, 
and Maria generated the mass spec data displayed in Figure 4.6 c, d, and e, and 
Figure 4.9. Timo Louisse helped screen the metabolic RNAi library, and 
contributed to Figure 4.3b and Table 4.3. Vicky Yao and Olga Troyanskaya 
contributed their unpublished WISP tool for building tissue-specific gene co-
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Abstract
 
Inborn errors of human metabolism are rare and often severe genetic disorders 
characterized by an inability to convert or breakdown cellular metabolites. 
Patients with inborn errors in vitamin B12 (B12)-dependent propionate 
breakdown build up high levels of propionate or methylmalonate (propionic 
acidemia or methylmalonic acidemia), depending on which enzyme in the 
pathway is mutated [138]. These diseases are diagnosed when unique aberrant 
metabolites such as 3-hydroxypropionate (3-HP) are observed in newborn 
screening [139]. The appearance of 3-HP, a propionate oxidation product, 
suggests that alternative propionate breakdown mechanisms may be utilized 
when the canonical pathway is perturbed [140]. However, the genetic pathway(s) 
that generate these metabolites and the biological significance of these pathways 
remains largely unknown. Using genetic interaction screening, metabolomics and 
13C propionate tracing, we identify a 3-HP-producing β-oxidation-like propionate 
breakdown shunt in the model organism Caenorhabditis elegans. This pathway is 
composed of five genes: acdh-1, ech-6, hach-1, hphd-1 and alh-8, which have 
clear human orthologs. All five genes are transcriptionally activated when dietary 
B12 levels are low and/or when propionate levels are high. The capacity to 
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switch between the canonical propionate breakdown pathway and the oxidation 
shunt provides C. elegans with metabolic flexibility to adapt to B12 availability. 
Results and Discussion
 
Humans and most animals, including C. elegans, require bacterially synthesized 
vitamin B12, or cobalamin, to support two essential metabolic pathways: the 
methionine/SAM cycle (or one-carbon cycle), and the breakdown of propionyl-
CoA to succinyl-CoA [113, 141] (Figure 4.1a). Propionyl-CoA is produced from 
odd chain fatty acid and branched chain amino acid breakdown, and is readily 
interconverted via acyl-CoA synthases with propionate, a short chain fatty acid 
produced by bacterial fermentation. C. elegans has clear orthologs of the human 
B12-dependent propionyl-CoA breakdown genes [113], as well as a highly 
conserved B12-processing system [41], and therefore provides a genetically 
tractable model to characterize metabolic network rewiring relevant to B12 
deficiency, and propionic and methylmalonic acidemias.  
C. elegans inhabits temperate climates across the globe, and feeds on a 
wide variety of bacteria found in rotting vegetation [107]. WIthin microbial 
communities studied to date, bacterial species with B12-synthesizing capacity 
are in the minority [142] and there is evidence that other community members 
compete for B12 uptake [143]. It is likely that C. elegans encounters some 
bacterial diets in its natural habitat that do not provide B12, and it is unlikely that 
C. elegans obtains B12 from other sources within its environment since plants, 
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fungi and yeasts do not synthesize or use it [144]. We previously found that 
supplementing B12 to bacterial diets lacking B12 biosynthesis capacity, such as 
E. coli OP50, induces robust metabolic gene expression changes in C. elegans 
[41]. This transcriptional response to B12 may lead to metabolic network 
rewiring, however the functionality of such rewiring remains unknown. 
Expression of C. elegans acyl-CoA dehydrogenase 1, acdh-1, is 
dramatically downregulated by dietary B12, and this repression occurs 
transcriptionally through its 1.5 kb promoter [41]. However, B12 supplementation 
is not sufficient to downregulate acdh-1 expression, as its repressive effects 
depend on the canonical B12-dependent propionate breakdown pathway, and 
can also be overridden with excess propionate supplementation [41]. Thus, acdh-
1 expression may be activated when levels of propionate or propionyl-CoA 
increase, such as when the canonical breakdown pathway is genetically 
inactivated, or when dietary B12 intake is insufficient.  
What is the function of the transcriptional upregulation of acdh-1 by 
propionate? Like mutations in canonical propionate breakdown pathway genes, a 
null mutation in acdh-1 renders animals sensitive to propionate-induced toxicity, 
a phenotype that is completely rescued by B12 supplementation (Figure 4.1b). 
Furthermore, acdh-1 mutants exhibit conditional embryonic lethality on low-B12 
diets, which can be rescued by supplementing B12 (Figure 4.1c). Based on 
these observations, we conclude that acdh-1 is required by C. elegans to survive 
B12 deficiency, and may function in propionate breakdown or detoxification. 
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 To test the relationship between acdh-1 and the canonical B12-dependent 
propionate breakdown pathway, we attempted to generate a Δacdh-1/Δpcca-1 
double null mutant. pcca-1 encodes the alpha subunit of the first enzyme in the 
canonical pathway (Figure 4.1a). A cross between Δpcca-1 and Δacdh-1 null 
mutants yielded no viable double homozygous mutant offspring (Figure 4.1d and 
Table 4.1). Since there were many dead eggs laid by the pcca-1-/-; acdh-1+/- 
hermaphrodites (Figure 4.2 and Table 4.1), we conclude that the double null 
mutant is synthetic embryonic lethal. As synthetic relationships are often 
observed between genes in redundant pathways [145, 146], we hypothesized 
that acdh-1 may function in a propionate breakdown shunt, transcriptionally 
activated when flux through the canonical pathway is inadequate, such as when 
B12 intake is suboptimal. 
To identify additional C. elegans genes that may function with acdh-1 in an 
alternate propionate breakdown pathway, we designed a synthetic lethality 
screen using Δpcca-1 mutants and an RNAi library of C. elegans metabolic 
genes. In contrast to the combination of null mutants, acdh-1 knockdown by 
dsRNA feeding in the Δpcca-1 mutant only resulted in complete lethality in the 
presence of 30mM propionate (Figure 4.3a), indicating that RNAi likely results in 
incomplete knockdown. Therefore, we screened for knockdowns that led to non-
viable offspring in the pcca-1 mutant with 30mM propionate, with less severe or 
no phenotypes in the other conditions (Figure 4.3b). The library targeted 836 
predicted metabolic genes (Table 4.2). After retesting first-pass hits from the 
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initial screen three times, we obtained three high-confidence hits: acdh-1, which 
validates the screening conditions, ech-6, an enoyl-CoA hydratase 6, and 
F09F7.4, which we will refer to henceforth as hach-1, a hydroxyacyl-CoA 
hydrolase. Seven lower-confidence hits were also retrieved from the screen that 
resulted in increased sensitivity to propionate when knocked down by RNAi, but 
displayed inconsistent or incomplete synthetic lethality with pcca-1.  (Figure 4.4 
and Table 4.3). We confirmed that RNAi knockdown of ech-6 and hach-1 in a 
wild type background results in sensitivity to propionate-induced toxicity. Similar 
to acdh-1 perturbation, this sensitivity is alleviated by B12 supplementation, 
supporting the hypothesis that these three genes may function together in a 
genetic pathway (Figure 4.4).  
The B12 independent yeast, Candida albicans, utilizes a β-oxidation-like 
propionate breakdown pathway rather than the B12-dependent carboxylation 
pathway. Recently, the C. albicans ortholog of HACH-1 was associated to the 
reaction 3-hydroxypropionyl-CoA ! 3-HP + CoA (E.C. 3.1.2.4) in the β-oxidation-
like propionate breakdown pathway [147]. Additionally, HACH-1 is predicted by 
KEGG [148] to catalyze the E.C. 3.1.2.4 reaction. While ACDH-1 and ECH-6 do 
not share sequence homology with the C. albicans proteins proposed to catalyze 
the first two reactions in the pathway, they are predicted to catalyze highly similar 
reactions. The human ortholog of ACDH-1, ACADSB, catalyzes the 
dehydrogenation of the C4 branched-chain substrate isobutyryl-CoA in valine 
breakdown, which is structurally similar to propionyl-CoA. Dehydrogenation of 
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both isobutyryl-CoA and propionyl-CoA involves a mono-substituted β-carbon, 
which is unique feature among acyl-CoA dehydrogenation reactions. ECH-6 is 
one of several C. elegans enzymes associated with the second reaction of the β-
oxidation-like propionate breakdown pathway by KEGG, which uses the E.C. 
number 4.2.1.17 to describe this and several similar reactions in BCAA 
breakdown. We therefore hypothesized that ACDH-1, ECH-6, and HACH-1 
function in a β-oxidation-like propionate breakdown shunt in C. elegans 
analogous to the Candida pathway that converts propionyl-CoA to acetyl-CoA 
(Figure 4.3c).  
The first reaction in the propionate oxidation shunt produces acrylyl-CoA 
that can be readily hydrolyzed to acrylate, both of which are highly reactive and 
toxic molecules [149, 150]. Acrylyl-CoA is the predicted substrate for ECH-6, our 
predicted second enzyme in the propionate oxidation shunt. Therefore, we 
hypothesized that ech-6 perturbation would result in more severe phenotypes 
than mutation in acdh-1 due to toxic acrylyl-CoA or acrylate buildup. Indeed, 
knockdown of ech-6 results in extremely slow growth and a “clear” phenotype 
(Figure 4.3d). Similar, albeit less severe, effects were observed with hach-1 
knockdown. The addition of B12 partially alleviates the detrimental effects 
caused by ech-6 or hach-1 knockdown. The partial rescue of ech-6 and hach-1 
knockdowns by B12 depends on the canonical B12 dependent pathway, as B12 
has no beneficial effect in pcca-1 mutants (Figure 4.3d). Importantly, Δacdh-1 
mutation largely suppressed the phenotypic effects of ech-6 and hach-1 
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knockdown, likely due to the lack of acrylyl-CoA production in the absence of 
acdh-1 (Figure 4.3d). This genetic buffering supports the placement of ech-6 
downstream of acdh-1.  
In KEGG, the β-oxidation-like propionate breakdown pathway includes two 
additional reactions that convert 3-HP into acetyl-CoA and CO2 (Figure 4.3c). To 
identify enzymes that may catalyze these reactions, we utilized WISP, a server 
for tissue-specific functional networks in C. elegans constructed from the 
integration of a large compendium of diverse datasets (Yao et al, in preparation; 
http://wisp.princeton.edu). The intestinal functional network centered on acdh-1, 
ech-6 and hach-1 and included high-confidence functional connections to 
Y38F1A.6 and alh-8 (Figure 4.3e), neither of which were screened in the RNAi 
library (Table 4.2). These genes are excellent candidates to catalyze the fourth 
and fifth reactions in the propionate oxidation pathway, respectively. Y38F1A.6 is 
orthologous to the human gene ADHFE1, a hydroxyacid-oxoacid 
transhydrogenase that has been shown to metabolize γ-hydroxybutyrate 
(GHB)[151]. GHB is a structural analog of 3-HP produced by γ-aminobutyric acid 
(GABA) breakdown and is commonly known for its use as a recreational drug 
[152]. We will henceforth refer to Y38F1A.6 as hphd-1 (3-hydroxypropionate-
oxoacid transhydrogenase). alh-8 is associated by KEGG to both E.C. 1.2.1.27, a 
reaction in branched chain amino acid breakdown, and E.C. 1.2.1.18, the fifth 
reaction in the propionate oxidation pathway, reactions that involve structurally 
similar substrates and products. Mutations in the human ortholog of alh-8, 
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ALDH6A1, result in 3-HP accumulation [153], which supports the placement of 
alh-8 in the propionate shunt. Like acdh-1, ech-6 and hach-1, the expression of 
hphd-1 and alh-8 is repressed by B12-synthesizing bacteria, Comamonas 
aquatica [29], as well as by B12 supplementation to the E. coli OP50 diet (Figure 
4.3f). Further, qRT-PCR experiments revealed that all five genes are activated by 
propionate (Figure 4.3f). These data demonstrate that hphd-1 and alh-8 are co-
regulated with acdh-1, ech-6 and hach-1 in response to metabolic cues. 
We obtained an hphd-1 deletion mutant from the Caenorhabditis Genetics 
Center (CGC), and generated an alh-8 deletion mutant by CRISPR/Cas9-
mediated genome editing [154] (Figure 4.5). Both mutants exhibit decreased 
propionate tolerance and partial larval lethality on a low-B12 diet, and both 
phenotypes were at least partially rescued by B12 supplementation (Figure 4.6 
a, b). The B12-mediated rescue of the partial lethality exhibited by the Δhphd-1 
mutant was dependent on a functional canonical propionate breakdown pathway, 
as B12 failed to rescue the partial larval lethality exhibited by the double mutant 
Δhphd-1;Δpcca-1 (Figure 4.6b). The double mutant Δhphd-1;Δpcca-1 also 
exhibited increased propionate sensitivity compared with either single mutant, 
indicating a genetic interaction between hphd-1 and pcca-1, and supporting the 
placement of hphd-1 in the same pathway as acdh-1 (Figure 4.7). We previously 
found that the acdh-1 promoter is activated by impaired propionate breakdown or 
by propionate supplementation [41, 64]. Knockdown of acdh-1, ech-6 and hach-1 
all activate the acdh-1 promoter [64]. Similarly, the loss-of-function mutant 
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Δhphd-1 activates the acdh-1 promoter, further supporting its role in propionate 
breakdown (Figure 4.8). 
3-HP is a unique metabolic intermediate produced by the propionate 
oxidation pathway – it is not produced by any other known metabolic pathway in 
any species [148]. Using liquid chromatography/selective reaction monitoring 
mass spectrometry (LC-SRM) we confirmed the presence of 3-HP in C. elegans 
(Figure 4.6c). 3-HP was detected in wild type animals, and we confirmed the 
peak identity by matching retention time, mass/charge ratio and MS/MS 
fragmentation spectra to a chemically synthesized 3-HP standard. We observed 
>4-fold increased 3-HP levels in Δpcca-1 mutants compared to wild type animals, 
supporting our hypothesis that the propionate oxidation shunt is activated when 
the canonical pathway is perturbed (Figure 4.6 c, d). This mirrors the elevated 3-
HP observed in human patients with propionic acidemia caused by PCCA/PCCB 
mutations [155]. Finally, we detected a >200-fold increase in 3-HP concentration 
in Δhphd-1 mutants compared to wild type animals (Figure 4.6 c, d), supporting 
our prediction that 3-HP is a substrate for HPHD-1.  
To verify that 3-HP is indeed derived from propionate, we performed 
carbon tracing by feeding Δhphd-1 mutant animals 20 mM 13C-labeled 
propionate. We detected the formation of 13C-3-HP, indicating C. elegans can 
indeed convert propionate to 3-HP (Figure 4.6e). Analysis of the E. coli OP50 
diet used in these experiments revealed no detectable 3-HP, indicating that it is 
not derived from the bacterial diet (Figure 4.6c). We did however detect ample 
149
propionyl-CoA in E. coli OP50 supplemented with propionate (3.38 nmol/mg 
protein), so the lack of 3-HP in E. coli was not simply due to lack of pathway 
substrate (Figure 4.9). 
 Taken together, our data support a two-pathway solution for propionyl-
CoA breakdown in C. elegans, which enables metabolic flexibility to withstand 
changes in dietary B12 availability. E. coli and other low-B12 bacterial diets 
transcriptionally activate expression of the shunt. On B12-replete bacterial diets, 
such as Comamonas aq., the B12-dependent pathway is likely preferred, since 
expression of the propionate shunt pathway genes is repressed (or simply not 
activated). It is likely that when B12 is present, the B12-dependent pathway is 
more efficient at metabolizing propionyl-CoA compared to the β-oxidation 
pathway due to the high redox potential between propionyl-CoA and acrylyl-CoA, 
the first oxidation pathway intermediate [156]. Other advantages of the canonical 
pathway over the oxidation pathway include the use of fewer enzymes, and the 
lack of production of toxic intermediates or byproducts. Thus we propose that the 
propionate oxidation pathway serves as a backup route for the B12-dependent 
pathway, and that its transcriptional response to propionate has evolved to 
enable survival on B12 deficient diets.  
The C. elegans genes that we have associated with propionate oxidation 
have clear human orthologs (Table 4.4), making it plausible that these genes are 
responsible for producing the propionate oxidation intermediate 3-HP observed in 
patients with propionic acidemia and methylmalonic acidemia. Recently another 
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propionate oxidation shunt intermediate, acrylyl-CoA, was detected in the urine 
metabolomes of patients with mutations in the human orthologs of ech-6 and 
hach-1, ECHS1 and HIBCH, supporting a role for these human genes in 
propionate oxidation [157]. While originally thought of as an “aberrant” metabolite 
since it was only detected in patients with propionate breakdown disorders, 3-HP 
has more recently been detected in healthy individuals [158].  
Human orthologs of our five C. elegans genes are each known to be 
involved in other pathways (Table 4.4), indicating that roles within propionate 
oxidation would be the result of promiscuous, or “moonlighting,” enzymatic 
activities. Enzymatic promiscuity is increasingly recognized as a common 
evolutionary mechanism to increase metabolic reaction space and to maintain 
metabolic flexibility [159]. It is unclear whether the C. elegans genes associated 
with propionate oxidation also serve in other metabolic pathways, though ech-6, 
hach-1, and alh-8 are assigned to at least one additional pathway in the KEGG 
database [148]. Future studies will reveal whether an alternate propionate 
oxidation pathway is active in human tissues and subject to metabolite-driven 
regulation like the C. elegans pathway.   
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Δacdh-1 mutant, but has no effect in the Δpcca-1 mutant. Three biological 
replicate curves are shown on the left, with average LD50’s +/- standard deviation 
on the right. Unpaired student’s T tests were used to calculate p values. Black 
asterisks indicate significant difference compared to wild type, red asterisks 
indicate significant difference compared to wild type + B12.  c. Δacdh-1 mutants 
cannot survive low B12 diets. Wild type animals and Δacdh-1 mutants were 
grown for one generation on media containing B12, and their F1 offspring were 
grown on soy peptone plates (that do not have B12), seeded with E. coli OP50, 
with or without 60nM B12. The F2 generation was collected and hatched 
overnight in the absence of food. Δacdh-1 mutant F2’s from F1 parents grown 
without B12 fail to hatch. d. A cross between Δpcca-1 and Δacdh-1 mutants 
yields no viable double homozygous mutants. pcca-1 +/+; acdh-1 +/- animals and 
pcca-1 -/-; acdh-1 +/- animals were grown on E. coli OP50 seeded plates 
containing 60nM B12, and individual F1s were picked onto new plates, also 
containing 60nM B12. The distribution of acdh-1 genotypes among the viable F1s 
picked from each P0 genotype is shown.  
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Table 4.1 – Summary of acdh41 genotypes in F1 generation of P0 pcca41 P/P; acdh41 +/P
animals.  
The acdh-1 genotype (homozygous, heterozygous, or wild type) as determined 
by PCR for each F1 animal chosen from P0 pcca-1 +/+; acdh-1 +/- or pcca-1 -/-; 
acdh-1 +/- parents is shown, as well as an indication of whether the F1 animal 
laid non-viable embryos among the F2 offspring. 
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Figure 4.2 – Double Δacdh41; Δpcca41mutation is embryonically lethal.
Related to Figure 4.1d. pcca-1 -/-; acdh-1 +/- hermaphrodites produce ~63% 
viable pcca-1 -/-; acdh-1 +/-, ~37% viable pcca-1 -/-; acdh-1 +/+, and 0% viable 
pcca-1 -/-; acdh-1 -/- offspring. Dead eggs are abundant on plates with pcca-1 
+/+; acdh-1 +/- parents, but not on plates with pcca-1 -/-; acdh-1 +/+ parents. It is 
likely that these dead eggs represent double homozygous mutants.  
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Figure 4.3 – An RNAi screen identifies candidate genes involved in alternate
propionate breakdown shunt.  
a. RNAi-mediated knockdown of acdh-1 results in synthetic lethality with the 
Δpcca-1 mutant in the presence of 30 mM propionate. Synthetic lethality in the 
presence of propionate is also observed in the reciprocal experiment, in which 
pccb-1, the beta subunit of propionyl-CoA carboxylase, is knocked down in the 
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Δacdh-1 mutant. Lethality is only observed in the second generation of RNAi 
knockdown, shown in representative DIC images. Δacdh-1 animals were 
cultivated with 64nM B12 one generation prior to the first generation of 
knockdown to support survival of this mutant. b. RNAi-screen of 836 metabolic 
genes in presence or absence of added propionate and in wild type and Δpcca-1 
mutant animals. Hits were retested three times. High-confidence hits, which 
retested all three times, are listed. Additional low-confidence hits are listed in 
Table 4.3. c. Enzymes that genetically interact with the canonical propionate-
breakdown pathway may form a parallel, β-oxidation-like propionate breakdown 
pathway. Reactions and associated enzyme-encoding genes of the canonical 
B12-dependent pathway are shown on top (orange boxes). Reactions and 
candidate enzyme-encoding genes of the proposed oxidation shunt are shown 
on bottom (green boxes = genes identified in screen; blue boxes = candidate 
genes identified bioinformatically). d. Genetic buffering of severe ech-6 and 
hach-1 RNAi phenotypes by loss of acdh-1 function. Representative DIC images 
of animals subjected to two generations of RNAi knockdown are shown. e, 
Candidates for the last two reactions in the proposed propionate oxidation shunt 
identified from an intestinal functional network around acdh-1, ech-6 and hach-1 
in WISP (in preparation; http://wisp.princeton.edu), with a minimum relationship 
confidence score of 0.7. hphd-1 and alh-8 (blue) are both tightly connected to 
acdh-1, ech-6 and hach-1 (green), and are candidates to catalyze the 4th and 5th 
reactions of the pathway, respectively. f, The expression of all five candidate 
propionate oxidation pathway genes is repressed by B12 and activated by 
propionate. Condition matrices are shown for each gene. Expression is 
normalized to levels in the control (0nM B12, 0mM propionate) condition. 
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Table 4.2 – Metabolic gene lists  
A manually curated list of putative metabolic genes in C. elegans. The 836 genes 
that were screened as part of the metabolic RNAi library are indicated. 
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Figure 4.4 – Validation of hits from screen.
a, ech-6 and hach-1 knockdown in wild type animals results in sensitivity to 
propionate-induced toxicity compared to the control (vector alone) treatment. B12 
supplementation partially rescues these phenotypes. Toxicity assays were 
performed with the respective gene-targeting dsRNA-expressing E. coli HT115 
clone in the presence of 1mM IPTG to induce dsRNA expression. Animals used 
in this assay had been exposed to respective dsRNA-expressing clones for one 
generation prior. To obtain enough viable animals to perform the assay, the ech-
6 targeting dsRNA-expressing clone was diluted 1:1 with the vector control clone 
to reduce knockdown efficiency, reducing the severely detrimental effects of loss 
of ech-6. b, Lower confidence hits from the screen reduced propionate tolerance 
when knocked down in wild type animals. However, these hits did not result in 
synthetic lethality with the pcca-1 mutant in the presence of 30mM propionate in 
every retest (see Table 4.3). 
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Figure 4.5 – Structure of Δhphd41mutant and CRISPR/Cas9Pgenerated Δalh48mutant.
Diagram of the mutation generated by CRISPR/Cas9-mediated genome editing 
using an sgRNA (red sequence) targeting alh-8. The mutation consists of a 23 bp 
indel and 399 bp deletion, and removes part of the 5’UTR, the start codon, the 
first and second exons, and part of the third exon. Also shown is the Δhphd-1 
mutation. 
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Figure 4.6 – Perturbation of predicted propionate breakdown shunt genes confers
propionatePsensitivity phenotypes and result in buildup of 3PHP, a unique pathway
intermediate.  
a, Δhphd-1 and Δalh-8 mutants exhibit sensitivity to propionate in toxicity assays 
compared to wild type animals. B12 increases propionate tolerance in both 
mutants, but does not completely rescue the sensitivity phenotype of alh-8 
mutant. Three biological replicate curves are shown on the left, with average 
LD50’s +/- standard deviation on the right. Unpaired student’s T tests were used 
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to calculate p values. Black asterisks indicate significant difference compared to 
wild type, red asterisks indicate significant difference compared to wild type + 
B12. b, Δhphd-1 and Δalh-8 mutants exhibit partial lethality on low-B12 
conditions. Animals were fed for one generation on E. coli OP50 supplemented 
with 60nM B12, then grown for one generation on the indicated diet. Offspring 
were harvested and live and dead L1s and embryos were quantified following an 
overnight arrest. Δacdh-1, Δhphd-1 and Δalh-8 mutant phenotypes were rescued 
by 60nM B12 supplementation or by the B12-producing bacteria Comamonas 
aquatic DA1877. The partial lethal phenotype of the double mutant Δhphd-
1;Δpcca-1 was not rescued by B12. Error bars depict standard error of the mean 
(SEM) from three biological replicates. c, 3-HP detection by liquid 
chromatography – the 3-HP chromatogram (Q1/Q3: 91->73 m/z) corresponds to 
a 3-HP concentration of 11.6, 59.8 and 302.5 picomoles/mg protein for wild type, 
Δpcca-1 and Δhphd-1, respectively.  3-HP was not present, or below the 
detection limit, of a selective reaction monitoring (LC-SRM) analysis of 
concentrated metabolite extract harvested from an E. coli pellet derived from 3L 
of saturated culture. d, Average 3-HP quantities normalized to total protein levels 
from four biological replicates, +/- SEM. Asterisks indicate p values < 0.001.  
Animals were grown in liquid culture seeded with E. coli OP50. e, 13C-labeled 
propionate fed to Δhphd-1 mutant animals for 2 hours results in 13C-labeled 
labeled 3-HP, indicating that C. elegans oxidizes propionate to 3-HP. Shown are 
SRM (MS2) chromatograms specific for 3-HP. The peak corrsesponding to the 
natural 13C isotope distribution (~ 1.1% of 12C signal) is illustrated for comparison 
in t=0. f, Model describing two-pathway solution for propionate breakdown in C. 
elegans. When B12 is available from the diet, C. elegans engages the canonical, 
B12-dependent pathway and represses expression of genes in the oxidation 
shunt. On low-B12 diets such as E. coli and other bacteria that do not synthesize 
the vitamin, the oxidation shunt genes are transcriptionally upregulated and this 
pathway is relied upon for survival. 
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Figure 4.7 – The double mutant Δpcca41;Δhphd41 is more sensitive to propionate.
a, Propionate toxicity assays were performed in biological triplicate for wild type, 
Δpcca-1, Δhphd-1, and a Δpcca-1; Δhphd-1 double mutant. b, Summary of 
propionate LD50’s indicate that the double mutant Δhphd-1;Δpcca-1 is more 
sensitive to propionate-induced toxicity compared to either the Δpcca-1 or Δhphd-
1 single mutant. Average LD50s derived from three biological replicates are 
shown +/- standard deviation. Unpaired student’s T tests were used to calculate 
p values. 
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Figure 4.9 – PropionylPCoA measurements in E. coli and C. elegans.
a, Despite the lack of 3-HP, we were readily able to measure propionyl-CoA in E. 
coli, suggesting the lack of 3-HP detection is not simply due to a lack of pathway 
substrate. The propionyl-CoA chromatogram correspond to 15.9, 2, 1.4 and 1.3 
picomoles/mg protein for E. coli+PA, wild type, Δpcca-1 and Δhphd-1, 
respectively. 
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Table 4.4 – Comparison of C. albicans propionate oxidation genes and C. elegans genes
proposed to form propionate shunt, with human orthologs.
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Experimental Procedures
C. elegans strains.  
N2 (Bristol) was used as the wild type strain, and animals were maintained 
as described (Brenner, 1974). Δpcca-1(ok2282), Δacdh-1(ok1489), Δmce-
1(ok243) and Δhphd-1(ok3580) strains were provided by the C. elegans Gene 
Knockout Consortium and were backcrossed 3 times against N2 prior to assays. 
The Δhphd-1(ok3580) allele was genotyped and sequenced using the primers 
CTCTGTAATGACAACCGCAGTGGC and 
CGTAAGGGACTTCTCGTACAGAGTGC. This allele removes only part of the C 
terminus of the protein and may not be a complete loss-of-function mutation. For 
a diagram of deletion mutant loci, see Figure 4.5 and for a full list of genotyping 
primers refer to Table 4.5. 
Propionate toxicity assays.  
Approximated 100 synchronized L1s (hatched overnight, 20hr post-
bleach) were added to E. coli OP50-seeded 35mM NGM (bactopeptone) agar 
plates containing various concentrations of pH-neutralized propionic acid. Each 
dose tested included 4 technical replicates. After 72 hours, un-arrested survivors 
(animals that had developed past L1 stage) were counted. Dose response curves 
were fit to the raw data using the following equation:  
Y=Bottom + (Top-Bottom)/(1+10^((LogLD50-X)*HillSlope)) 
The dose required to kill 50% of the population (LD50) was calculated according 
to the fitted dose response curves. Toxicity assays were performed in biological 
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triplicate, and the average LD50’s are plotted +/- SEM. To obtain enough viable 
Δacdh-1 mutant animals for these assays, 64nM B12 was supplemented to 
animals two generations prior to assay.  
RNAi screen with metabolic library.  
A list of metabolic enzyme domain-containing genes was manually 
curated based on KEGG and WormBase databases, and available metabolic 
gene-targeting clones in the ORFeome RNAi library were re-arrayed in 96 well 
format. See Table 4.2 for these gene lists. RNAi experiments were performed as 
follows: 24-well NGM (bactopeptone) agar plates containing 1mM IPTG and 
1mM Ampicillin were seeded with one dsRNA-expressing E. coli HT115 clone 
per well the night before use. A separate set of plates containing 30mM pH-
neutralized propionate was also prepared and seeded with the same HT115 
clones. The HT115 cultures were prepared by seeding 1 mL fresh LB + Ampicillin 
with 50 uL overnight culture, growing at 37oC for 6 hours, then centrifuged and 
resuspended in 150 uL LB + Ampicillin. 30 uL of this resuspended culture was 
placed in the center of NGM wells in the 24-well plates. Wild type and Δpcca-1 
mutants were cultivated on E. coli OP50, and eggs were harvested by bleaching, 
and hatched overnight in M9 media (20 hours), and synchronized L1s were 
added to prepared plates. Animals were observed after 3 days to observe effects 
in the 1st generation, and after 6 days to observe lethality in the 2nd generation. 
qPCR experiments  
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Animals were synchronized by L1 arrest and grown on plates containing 
bactopeptone and various doses of B12 and/or propionate, seeded with E. coli 
OP50. Approximately 1500 adult animals were harvested for each condition, in 
biological duplicate. Animals were washed in M9 buffer, and total RNA was 
isolated using Trizol (Invitrogen) followed by DNAseI treatment and cleanup 
using Qiagen RNeasy columns. cDNA was prepared from RNA using oligo-dT 
and Mu-MLV enzyme (NEB). Primer sequences for quantitative RT-PCR (qRT-
PCR) were generated using the GETprime database [97] and are listed in Table 
4.5. qPCR was performed in technical triplicate per gene per condition using the 
Applied Biosystems StepOnePlus Real-Time PCR system and Fast Sybr Green 
Master Mix (Invitrogen). Relative transcript abundance was determined using the 
ΔΔCt method [160], and normalized to averaged ama-1 and act-1 mRNA 
expression levels. 
C. elegans liquid culture.  
Synchronized animals were cultivated on 15cm NGM plates seeded with 
E. coli OP50, and bleached after 3 days. Bleached eggs were washed 3 times in 
M9, then allowed to hatch for 20 hrs. 1 million synchronized L1s were added to 
400 mL liquid NGM in a 2L Erlenmeyer flask, containing concentrated E. coli 
OP50 bacteria from 500mL overnight LB culture, and total volume was adjusted 
to 450 mL with M9. Some flasks contained 20mM pH-neutralized propionic acid. 
Flasks were kept at 20C, shaking gently at 100rpm. Each day concentrated 
bacteria were added to the flasks to feed the worms. Adult animals were 
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collected (after 3 days of development for N2, and 4 days for the mutants) and 
washed 2 times in M9 in sterile Imhoff settling cones. The final pellet was flash-
frozen and stored at -80oC until extraction.  
C. elegansmetabolite extraction.  
Cell extracts were obtained by re-suspending the frozen C. elegans or 
bacterial pellets in 4 mL of 5% trichloroacetic acid (TCA). Cell suspensions were 
homogenized in a Polytron PT 1300 for 2 min at 20,000 rpm and neutralized with 
1 mL of 2M of potassium monoacid phosphate. The samples were centrifuged at 
high speed for 10 min at 4oC and immediately injected for propionyl-CoA 
determination. The pellets were stored for protein quantification using the 
bicinchoninic acid method (Thermo Scientific Pierce Protein BCA Kit). For 3-HP 
measurements, the cell extract was desiccated in a Speedvac and the resulting 
pellet was resuspended in the same volume of methanol. Then, the samples 
were centrifuged at high speed for 10 min at 4oC. For E.coli metabolite 
extraction, the cell extracts were obtained as mentioned above except that 
bacteria cells were disrupted by sonication for 2 min using intervals of 15 
seconds of sonication followed by 15 seconds for cooling. 
LCPMS/MS Quantification
The quantification of metabolites was performed using a LC-MS/MS 
system consisting of an ultra-high pressure LC system (Agilent 1290) online 
coupled to a Triple Quadrupole mass spectrometer equipped with an 
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electrospray ionization source (Agilent 6460). Propionyl-CoA was separated 
using a column Zorbax Eclipse Plus C18 Rapid Resolution HD 2.1x50 mm 1.8 
Micron (Agilent) at 30 C.  The mobile phase was composed of Buffer A: 10 mM 
tributylamine, 15 mM acetic acid and 5% methanol; and Buffer B: 100% 
methanol. The flow rate was 0.5 mL/min and the gradient method consisted of: 0-
0.25 min, 2.5 %B; 0.25-0.5 min, 2.5-30 %B; 0.5-5 min, 30-70%B; 5-5.25 min, 70-
100% B; 5.25-6.25 min, 100% B; 6.25-7 min, 2.5 %B; 7-8 min 2.5% B.  The 3-
hydroxypropanoic acid was separated using a column Zorbax Eclipse Plus C18 
Rapid Resolution HD 2.1x100 mm 1.8 Micron (Agilent) at 30 C.  The mobile 
phase was composed of Buffer A: 0.1% formic acid in water; and Buffer B: 100% 
methanol. The flow rate was 0.35 mL/min and the gradient consisted of: 0-3 min, 
5 %B; 3-4 min, 5-70 %B; 4-5.25 min, 70%B; 5.25-5.5 min, 70-100% B; 5.5-6.5 
min, 100% B; 6.5-7 min, 5 %B; 7-7.5 min 5% B. Q1/Q3 (MRM) transitions, ion 
source and collision energy settings were optimized according to the metabolites 
and were: 91->73, 25 eV; 824.2->317.1, 25 eV; and 92->74, 25 eV (in positive 
mode),  for 3-HP, propionyl-CoA and 13C labeled 3-HP, respectively . Ion source 
settings were as follows: gas temperature, 300 C: gas flow, 8L/min; nebulizer 50 
psi (Nitrogen); sheath gas temperature, 200 C: sheath gas flow, 11 L/min, 
capillary 3500 V and nozzle voltage, 500 V. 
CRISPR/Cas9 genome editing
The alh-8 mutant was generated by dual sgRNA directed-deletion [161]. We 
used a co-CRISPR strategy, which includes unc-22 as a CRISPR marker to 
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enhance detection of genome-editing events [154]. The target sequences were 
manually derived to conform to the sequence N19NGG near the 5’ end of alh-8. 
Two target sequences were chosen: CCGCCCATCTCTTGTGATTTTC and 
CTGTGCGACAGTTGTCGTATGG. We designed forward and reverse oligomers 
containing the N19 sequence and ends of BsaI recognition sites. The forward 
and reverse oilgomers were annealed and ligated to BsaI-digested pRB1017 
vector [162]. The alh-8 sgRNA plasmids were prepared using a PureLink Quick 
Plasmid Miniprep Kit (Invitrogen). The other coinjected DNA vectors were purified 
using a Qiagen midiprep kit. The DNA mixture used in microinjection contained 
Peft-3::Cas9 vector, pRF4::rol-6(su1006), unc-22 sgRNA vector (all gifts from the 
Mello lab) and two alh-8 sgRNA vectors, each with a concentration of 40 ng/µl. 
Approximately 20 young adult hermaphrodite worms were injected. After 
recovering from injection, each worm was placed onto an individual E. coli OP50 
plate. After 2-3 days, the F1 rollers (dominant phenotype indicating presence of 
the pRF4::rol-6(su1006) construct) were picked onto new plates. F1s with 
twitcher F2s were genotyped by PCR for mutations in alh-8. The PCR primers 
are outside of the sgRNA-targeted region. Forward primer: 
TTCAATGTTCGCGTGTATTTTG; Reverse primer: TCAGCGAGCTTCTTCATGT. 
The amplicons with smaller size than wild type amplicons were reconfirmed by 
sequencing. Forward primer: ATTCGAAACGTGATCAGTAATG; Reverse primer: 
CTCTCTTGATCAAGGCTTGA. A mutant animal with a ~400bp deletion (23 bp 
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indel and 399 bp deletion) was chosen for further analysis, and was outcrossed 
with N2 three times before use in phenotypic assays. 
Network Analysis
The WISP tissue-specific functional networks were built using a semi-supervised 
regularized Bayesian approach that integrated 56,179 expression- and 
interaction-based measurements across 174 genome-level datasets [in 
preparation; http://wisp.princeton.edu]. Using the intestine network, we found 
genes that were tightly connected to acdh-1, ech-6 and hach-1 even after 
adjusting for average network connectivity, which improved the specificity of the 
retrieved genes to our seed genes. 
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CHAPTER V: CONCLUSIONS AND FUTURE DIRECTIONS
 
Preface
This conclusions chapter is partially adapted from a review written by 
myself, Safak Yilmaz, and Marian Walhout, to be published in the journal Annual 
Review of Genetics in 2015, titled, “Understanding Metabolic Regulation at a 
Systems Level: Metabolite Sensing, Mathematical Predictions, and Model 
Organisms.” (Watson et al, in press) 
Introduction
Most of what is known about the mammalian metabolic network comes 
from a century of enzymology research, in which enzyme activities were 
detected, functionally purified, and eventually genetically characterized. The 
current age of genomics has enabled the study of metazoan metabolism at a 
genome-wide, or systems-, level. Genome sequencing has revealed a predicted 
parts list of the metabolic network, and there are hundreds of enzyme-domain 
containing genes whose functions are yet to be determined. Transcriptomic and 
proteomic studies have revealed that metabolic networks exhibit great diversity 
between tissues, during proliferation versus senescence, and in health versus 
disease. This differential use of metabolic subnetworks or pathways is referred to 
as metabolic network rewiring. Today we are challenged with understanding 
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which metabolic pathways are employed in which tissues and under which 
conditions, and how control systems drive metabolic rewiring. 
To explore metabolic network rewiring we must consider both the 
mechanisms and outputs of metabolic network regulation. Mechanistically, 
metabolic genes are extensively regulated at the levels of transcription [163], 
post-transcription [164-166], post-translation [167, 168] including allostery 
through direct interactions with metabolites [169-171], and subcellular localization 
[172, 173]. Further, the regulators are themselves regulated at multiple levels
[174] and are connected to master endocrine signaling pathways that coordinate 
metabolism across tissues [175]. Understanding how metabolic network 
regulation affects global outputs (phenotypes) is another major challenge. 
Predictions about the output of metabolic network rewiring can be generated 
through stoichiometric metabolic network models, which are built by 
comprehensively annotating the collection of enzymes encoded by the genome 
and the reactions they are likely to catalyze. The power of this approach is that 
such models can provide nonintuitive metabolic and physiological hypotheses. 
An advantage of these models is that “omics” data can be integrated into the 
network model to investigate tissue- and condition-specific metabolic programs, 
such as metabolite and enzyme dependencies of cancer cells [176]. 
A complementary approach for exploring metabolic network function is to 
utilize forward and reverse genetics to identify the genes responsible for 
metabolic phenotypes or metabolic rewiring events in vivo. Metazoan model 
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organisms such as Caenorhabditis elegans offer a platform for high-throughput 
genetic screening to uncover novel functions and biological roles of metabolic 
enzymes, as well as the regulatory networks involved in metabolic network 
rewiring. C. elegans is particularly powerful because in addition to being 
genetically tractable itself, its bacterial diet can also be subjected to systematic 
mutagenesis.  
We have taken advantage of this interspecies system to identify, in an 
unbiased fashion, the most important players in the orchestration of C. elegans 
metabolic states induced by different amounts of bacterially supplied vitamin 
B12. We serendipitously found an alternate metabolic shunt in C. elegans by 
studying these diet-responsive gene networks, which we believe is a target of 
metabolic rewiring induced by insufficient flux through the parallel (canonical) 
pathway. Our studies provide a blueprint for identifying other interspecies genetic 
interactions, which may dictate other metabolic or physiological states (Figure 
5.1). This chapter will discuss the implications, unanswered questions, and future 
directions from the work presented in this thesis. 
Metabolite Sensing and Transcriptional Regulation of Metabolic Enzymes
 Many questions remain regarding the mechanisms behind the 
transcriptional regulation of acdh-1 and other genes in response to vitamin B12 
and propionate. Is vitamin B12 directly sensed to repress the acdh-1 promoter, or 
is propionate (or some other derivative) the molecule that is sensed within the 
acdh-1 regulatory system, or is it both? The fact that B12 fails to repress acdh-1 
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expression when the B12-dependent propionyl-CoA breakdown pathway is 
genetically inactivated [41], suggests that B12 alone is not sufficient to repress 
acdh-1 under all conditions. If vitamin B12 is not sensed directly, its repressive 
effects occur entirely via enhancing flux through the canonical propionate 
breakdown pathway to reduce propionate/propionyl-CoA levels, thus lowering the 
activation signal. If vitamin B12 is sensed directly as part of the regulation of 
acdh-1, then sufficient levels of the propionate/propionyl-CoA activation signal 
can override the B12 repression signal. The latter system requires two sensing 
components, while the former system requires only one.  
 While there have been none discovered to date in animals, direct B12-
binding riboswitches are prevalent in bacteria, where they regulate the translation 
of genes involved in B12 import and processing [177, 178]. The only 
mechanisms of cellular vitamin sensing that have been described in metazoans 
to date are the vitamin D and vitamin A sensing systems, both of which involve 
direct binding by a nuclear hormone receptor. Vitamin D, while technically a 
hormone rather than a vitamin given that it can be synthesized from cholesterol 
in the skin upon UV light exposure, regulates the uptake of calcium, iron, 
magnesium, and zinc [179]. This regulation occurs through Vitamin D receptor 
(VDR)-mediated transcriptional activation of the transporters of these 
micronutrients [180]. Vitamin A, a true vitamin derived from plant carotenoids that 
takes several forms, has a plethora of functions in diverse processes, including 
development, vision, and immunity [181]. Vitamin A does not function in anabolic 
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or catabolic processes as most other vitamins but rather serves as a light-
sensing cofactor for rhodopsin and a signaling morphagen to regulate hox genes 
during development via retinoic acid receptor (RAR) binding [181]. There are 
enzymes that modify Vitamin A (retinol) to generate retinal (the form utilized by 
rhodopsin) and retinoic acid (the form that directly binds and activates RAR), as 
well as enzymes that degrade retinoic acid. Vitamin A metabolism is tightly 
regulated by positive and negative FBLs to maintain proper concentrations of the 
various forms of Vitamin A during development, given that dysregulation can lead 
to teratogenesis [182, 183]. For instance, the retinoic acid--degrading enzyme 
CYP26A1 is directly activated by RAR through binding of highly conserved 
retinoic acid response elements (RAREs) in its promoter [182]. Thus, retinoic 
acid activates its own degradation, preventing deleteriously high levels of retinoic 
acid from building up. Retinoic acid also represses the expression of the 
enzymes involved in its synthesis from retinol, although the mechanisms of this 
repression are unknown [182].  
 Less is known about the mechanisms employed by metazoan cells to 
sense other vitamins, if they do exist. However, gene expression studies in 
mammalian cells have revealed regulatory responses to vitamins B1 (thiamine) 
[184-186], B2 (riboflavin) [187], B3 (nicotinamide/niacin) [188-190], B6 (pyridoxal 
5 phosphate, PLP) [191, 192], B9 (folic acid) [193-195], C (ascorbic acid) [196-
198], and E (tocopherol/tocotrienols) [199-201]. It will be interesting to know the 
mechanisms by which cells sense vitamin intake and regulate genes accordingly, 
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to determine whether vitamins are sensed directly or indirectly through 
monitoring flux through their dependent pathways, which we have shown may at 
least be part of the story with vitamin B12 sensing in C. elegans.
 To understand whether C. elegans senses vitamin B12 intake directly, 
indirectly, or both, identification and interrogation of the metabolite-sensing 
components in the acdh-1 regulatory system are required. We identified 
candidate metabolite-sensing system components in our genome-wide RNAi 
screen for effectors of acdh-1 promoter activity [64]. Interestingly, two nuclear 
hormone receptors identified as acdh-1 activators from the screen (nhr-10 and 
nhr-68) were broadly required for the acdh-1-activating effect of canonical 
propionate breakdown pathway disruption [64]. In other words, when nhr-10 or 
nhr-68 was knocked down by RNAi, loss of pcca-1, mce-1, and mmcm-1 all failed 
to activate Pacdh-1::GFP [64]. This suggests that nhr-10 and/or nhr-68 are 
involved in sensing propionate metabolism flux, which is dictated by vitamin B12 
concentrations, and activating acdh-1 accordingly. Since nuclear hormone 
receptors possess both DNA-binding and ligand-binding domains, they are 
excellent conduits through which small molecule signals can be transmitted to 
the genome to affect gene expression. Future experiments will reveal whether 
nhr-10 and/or nhr-68 are involved in the direct binding of metabolites from 
propionate metabolism, or perhaps propionate/propionyl-CoA itself, or whether 
they are the downstream targets of the actual metabolite sensor. Either way, they 
appear to be components of a metabolic homoestatic system centered on 
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propionate metabolism.  
 Metabolic homeostatic systems utilize negative feedback loops (nFBLs), 
which are known to confer the properties of robustness [202] and adaptability 
[22, 203] to biological networks. Oftentimes the goal of a metabolic nFBL is to 
maintain a metabolite within a certain concentration threshold, thus metabolic 
nFBLs center around metabolites. In these nFBLs, metabolites serve as both the 
currency of communication between the metabolic network and its regulators, 
and the commodities that are ultimately regulated. Metabolic nFBLs include 
additional components such as enzymes to modify metabolite concentrations, 
regulators to regulate enzyme expression or activity, and sensors to monitor 
metabolite levels [204]. For example, the cellular ATP control system operates as 
an nFBL to maintain appropriate energy levels (Figure 5.2). In this system, 
AMP:ATP ratios are sensed by AMPK, which serves both sensor and regulator 
functions. AMPK is activated when ATP levels drop relative to AMP levels, and in 
turn phosphorylates glycolytic enzymes among other metabolic targets to 
enhance glycolytic flux, ultimately increasing ATP production. As ATP levels 
increase, AMPK is inhibited, which completes the feedback loop. Other metabolic 
nFBLs are described in Figure 5.2. 
 Is there an nFBL in C. elegans to monitor and regulate propionate levels? 
The answer would appear to be Yes. We have obtained evidence that i) 
propionate activates the acdh-1 promoter [41], ii) mutation of acdh-1 also 
activates its own promoter [64], and iii) acdh-1 likely functions in an oxidative 
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propionate breakdown shunt (Watson et al, in preparation; Chapter IV). Thus 
propionate would activate its own breakdown through a self-regulating nFBL 
(which includes acdh-1 and its activators nhr-10 and nhr-68 as key components) 
to maintain cellular levels within a certain threshold. If propionate levels can be 
used as an inverse proxy for measuring vitamin B12 levels (since B12 dictates 
propionyl-CoA breakdown flux through the canonical pathway) then there may be 
no need for a direct vitamin B12 sensor. Monitoring and regulating propionate 
levels maybe be advantageous since its buildup can be toxic.  
Propionate Metabolism
 Metabolic networks evolve to maximize efficiency and flexibility, to enhance 
the system’s robustness to changes in resource availability. In nature, multiple 
routes can arise to solve the same chemical problem, with more efficient routes 
evolving for instance if a chemical cofactor is available from the diet or 
environment. Thus, metabolic alliances exist between vitamin-synthesizing 
bacteria and vitamin auxotrophs, like humans [205, 206] and our model organism 
C. elegans. Propionate metabolism is an excellent example of this phenomenon. 
Several metabolic solutions exist in nature to breakdown this abundant C3-chain 
fatty acid: a carboxylation-based pathway that utilizes vitamin-derived cofactors, 
and several other pathways, including an oxidation pathway, that do not. 
 Propionate isn’t efficiently broken down by β-oxidation like it’s C4- and 
longer-chain fatty acid counterparts, likely due to a basic principle in organic 
chemistry summarized by Zaitsev’s rule, which states that alkane elimination 
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reactions proceed to generate the most stable possible alkene, which is the 
alkene with the most highly substituted double bond carbons. The β-carbon of 
C3-chain propionyl-CoA is monosubstituted, while the β-carbon in C4 butyryl-
CoA (and all longer chain acyl-CoAs) is disubstituted (Figure 5.3). This results in 
a high redox potential between propionyl-CoA and its unstable dehydrogenated 
form, acrylyl-CoA, rendering propionyl-CoA a poor substrate for β-oxidation [156]. 
Nature has solved this problem with a completely different C3-chain fatty acyl-
CoA catabolic pathway. This pathway begins with the carboxylation of propionyl-
CoA using bicarbonate as a co-substrate, which requires bacterially synthesized 
biotin. The next reaction is an epimerization, followed by a unique carbon 
skeleton rearrangement to form succinyl-CoA, which requires bacterially 
synthesized vitamin B12. Succinyl-CoA, when fully oxidized, yields more ATP 
than the products of direct propionyl-CoA oxidation, acetyl-CoA and CO2, thus 
the B12-dependent pathway may be both more efficient and more energy 
yielding. Vitamin B12 auxotrophs, including C. elegans and mammals, encode 
enzymes for the vitamin-dependent pathway, while B12 non-users like C. 
albicans utilize the vitamin-independent β-oxidation-like pathway [147] or the 
methylcitrate cycle [207].  
 Efficient breakdown of propionate is not only advantageous from an energy 
generation perspective, but also from a toxicity prevention perspective, as 
propionate buildup can be highly toxic. Propionate inhibits core TCA cycle 
enzymes and poisons the mitochondrial electron transport chain (ETC) [208], 
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depletes vital CoA pools [209] and acts as a potent HDAC inhibitor leading to 
histone hyperacetylation [210]. Perhaps this is why B12-independent organisms 
such as C. albicans that rely on the less efficient β-oxidation-like propionate 
breakdown pathway have a relatively low tolerance for propionate in the 
environment [147]. In fact, propionate is used industrially as an anti-fungal food 
preservative [211]. The “advantage” that B12 auxotrophs have over yeast with 
respect to propionate breakdown applies only when there is ample B12 in the 
organism’s diet. This begs the question, how do B12-dependent organisms avoid 
propionate-induced toxicity when B12 intake is suboptimal? We believe that for 
C. elegans, the answer to this question is that they maintain two pathways – one 
B12-dependent, and the other B12-independent. The B12-independent oxidative 
propionate breakdown shunt is transcriptionally upregulated upon B12 deficiency 
in an elegant example of metabolic rewiring as an adaptive response to diet. 
Mutating genes in the oxidative shunt renders animals more sensitive to B12 
deficiency. The major question remains, do humans (and other B12 auxotrophs) 
also maintain this oxidative propionate breakdown shunt? 
 There are some tantalizing clues to suggest that humans directly oxidize 
propionate. In fact the oxidative shunt was first hypothesized to exist in humans 
over 40 years ago [140], however it has never been characterized at the genetic 
level, its existence in healthy individuals has remained unproven, and it’s 
biological significance in mammals (if it does indeed exist) is unknown. The main 
support for the existence of a human propionate oxidation shunt is the detection 
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of 3-hydroxypropionate (3-HP), a unique intermediate in the pathway, in fluids 
from patients with propionic acidemia (PA), a condition of propionate buildup due 
to genetic mutations in the canonical B12-dependent breakdown pathway [140]. 
Elevated 3-HP is currently used as a diagnostic marker for PA in newborn 
screening [155]. More recently, global metabolomic profiling studies have 
revealed trace amounts of 3-HP in the urine of healthy subjects [158, 212]. 
Though it has been confirmed through carbon tracing experiments that the 3-HP 
observed in PA patients does in fact come directly from propionate [140], it is 
unclear whether humans truly have a devoted propionate oxidation pathway. To 
find the answer, the enzymes that contribute to the production of 3-HP in humans 
must be identified.  
 Humans have one-to-one orthologs (defined as reciprocal best BLAST hits) 
of our C. elegans oxidative shunt genes acdh-1, ech-6, hach-1, hphd-1, and alh-
8. The closest human homolog of acdh-1 is ACADSB, a short-branched chain 
acyl-CoA dehydrogenase that functions in valine and isoleucine breakdown. 
acdh-1 also has high sequence similarity to the human ACADS gene, which 
functions in β-oxidation as a short-chain (C4-C6) acyl-CoA dehydrogenase. The 
human orthologs of ech-6 and hach-1, ECHS1 and HIBCH respectively, are 
predicted to function primarily in branched chain amino acid (BCAA) breakdown, 
suggesting these enzymes would be required to “moonlight” if they indeed also 
function in the propionate shunt. Supporting this notion, HIBCH has been shown 
to metabolize structurally analogous intermediates from both BCAA breakdown 
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and the propionate oxidation shunt by in vitro biochemical assays [213, 214]. 
Recently, ECHS1 and HIBCH mutations were associated with acrylyl-CoA 
buildup in the urine of patients with inborn errors of metabolism [157].  
 Our candidate C. elegans 3-HP dehydrogenase hphd-1 is the first gene to 
be associated with 3-HP dehydrogenase activity in a metazoan. The human 
ortholog of hphd-1, ADHFE1, is not assigned to any pathways in the human 
metabolic network by KEGG or BRENDA databases, but has been shown to 
metabolize the drug/neurotransmitter γ-hydroxybutyrate (GHB) [151], a structural 
analog of 3-HP derived from GABA breakdown. The ADHFE1 reaction is unique 
in that it uses the TCA cycle intermediate α-ketoglutarate (α-KG) as an electron 
acceptor, and in the process generates the “byproduct” (D)-2-hydroxyglutarate 
(D2HG) – an oncometabolite that is also produced by gain of function mutants of 
IDH1 and IDH2 frequently found in cancer [215, 216]. If ADHFE1 also has 3-HP 
dehydrogenase activity coupled to α-KG reduction and D2HG production, a novel 
link will be revealed between propionate metabolism and oncometabolite 
production. Future experiments will determine whether C. elegans HPHD-1 
requires α-KG as a co-substrate, and whether it is also involved in GABA 
breakdown in C. elegans.   
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Figure 5.1 – Dissecting dietPrelated phenotypes in Caenorhabditis elegans with
interspecies genetics.
To determine gene networks involved in diet-related phenotypes in C. elegans, 
genetic screens can be performed in both the bacterial diet and in the animal. C. 
elegans can be fed a library of mutant bacteria to determine bacterial genes that, 
when mutated, lead to a particular phenotype. To identify C. elegans genes that 
are involved in the diet-associated phenotype, animals can be fed a library of 
dsRNA-expressing bacteria targeting individual C. elegans genes. Hits from 
either screen should be retested and validated, and can be built into gene 
networks based on coexpression, co-complex formation, and/or genetic 
interaction data, or metabolic pathway annotations. Hypotheses about 
interspecies gene network interactions and their consequences with respect to 
the metabolic phenotype can be generated and further tested. 
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Figure 5.2 – Feedback loops in metabolic network regulation
Feedback loops can consist of small molecules (triangles), regulators (squares), 
and enzymes or other metabolic gene targets (circles). Edges from metabolites 
to regulators indicate a repressive (red) or activating (green) effect of a 
metabolite on regulator function, with the sensing mechanism noted along edge. 
Edges from regulators to enzymes or metabolic genes indicate a repressive (red) 
or activating (green) effect on target function. Edges are marked P to indicate 
phosphorylation or T to indicate transcription. Edges from enzymes/metabolic 
genes to metabolites indicate a consuming (red) or producing (green) 
relationship. 
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Figure 5.3 – C2PC3 dehydrogenation of propionylPCoA vs. butyrylPCoA.
The high redox potential for the propionyl-CoA/acrylyl-CoA pair indicates that 
dehydrogenation of propionyl-CoA is thermodynamically less favorable than 
dehydrogenation of butyryl-CoA. Redox potentials are listed on the right.  
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